var title_f42_2_43040="Digital hair tourniquet removal";
var content_f42_2_43040=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F79634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F79634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Hair tourniquet removal",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Digit anatomy and recommended incision sites for removal of a hair tourniquet. When incising a constricting band on a digit, the neurovascular bundles can be avoided by choosing the 3 o'clock or 9 o'clock position. The incision should be made longitudinally in the proximal to distal direction, with the scalpel blade perpendicular to the surface of the skin. To ensure that the hair is cut completely, the incision should be to the depth of bone.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43040=[""].join("\n");
var outline_f42_2_43040=null;
var title_f42_2_43041="Patient information: Constipation in children (The Basics)";
var content_f42_2_43041=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15387\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/61/29661\">",
"         Amount of fiber in different foods",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?9/5/9299\">",
"         Patient information: Diarrhea in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?33/34/34338\">",
"         Patient information: Diarrhea in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?26/59/27570\">",
"         Patient information: Fecal incontinence in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?25/24/25986\">",
"         Patient information: Stomach ache and stomach upset (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?15/7/15477\">",
"         Patient information: Constipation in infants and children (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Constipation in children (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/constipation-in-children-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H462784490\">",
"      <span class=\"h1\">",
"       How often should my child have a bowel movement?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It depends on how old he or she is:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        In the first week of life, most babies have 4 or more bowel movements each day. They are soft or liquid.",
"       </li>",
"       <li>",
"        In the first 3 months, some babies have 2 or more bowel movements each day. Others have just 1 each week.",
"       </li>",
"       <li>",
"        By age 2, most kids have at least 1 bowel movement each day. They are soft but solid.",
"       </li>",
"       <li>",
"        Every child is different. Some have bowel movements after each meal. Others have bowel movements every other day.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H462784497\">",
"      <span class=\"h1\">",
"       How will I know if my child is constipated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your child may:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Have fewer bowel movements than normal",
"       </li>",
"       <li>",
"        Feel pain when having a bowel movement",
"       </li>",
"       <li>",
"        Arch his or her back and cry (if still a baby)",
"       </li>",
"       <li>",
"        Avoid going to the bathroom, do a &ldquo;dance,&rdquo; or hide when he or she feels a bowel movement coming. This often happens when potty training and when starting school.",
"       </li>",
"       <li>",
"        Leak small amounts of bowel movement into the underwear (if he or she is toilet trained)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H462784504\">",
"      <span class=\"h1\">",
"       What if my child gets constipated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;In most children with mild or brief constipation, the problem usually gets better with some simple changes. Have your child:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Eat more fruit, vegetables, cereal, and other foods with fiber (",
"        <a class=\"graphic graphic_table graphicRef52349 \" href=\"mobipreview.htm?28/61/29661\">",
"         table 1",
"        </a>",
"        )",
"       </li>",
"       <li>",
"        Drink some prune juice, apple juice, or pear juice",
"       </li>",
"       <li>",
"        Drink at least 32 ounces of water and drinks that aren&rsquo;t milk each day",
"       </li>",
"       <li>",
"        Avoid milk, yogurt, cheese, and ice cream",
"       </li>",
"       <li>",
"        Sit on the toilet for 5 or 10 minutes after meals, if he or she is toilet trained. Offer rewards just for sitting there.",
"       </li>",
"       <li>",
"        Stop potty training for a while, if you are working on it",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H462784511\">",
"      <span class=\"h1\">",
"       When should I take my child to the doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You should have your child seen if:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        He or she is younger than 4 months old",
"       </li>",
"       <li>",
"        He or she gets constipated often",
"       </li>",
"       <li>",
"        You have been trying the steps listed above for 24 hours, but your child has still not had a bowel movement",
"       </li>",
"       <li>",
"        There is blood in the bowel movement or on the diaper or underwear",
"       </li>",
"       <li>",
"        Your child is in serious pain",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H462784518\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/5/9299?source=see_link\">",
"       Patient information: Diarrhea in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/34/34338?source=see_link\">",
"       Patient information: Diarrhea in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/24/25986?source=see_link\">",
"       Patient information: Stomach ache and stomach upset (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?26/59/27570?source=see_link\">",
"       Patient information: Fecal incontinence in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/7/15477?source=see_link\">",
"       Patient information: Constipation in infants and children (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?42/2/43041?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15387 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-2.133.93.82-3DA446CC7F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43041=[""].join("\n");
var outline_f42_2_43041=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462784490\">",
"      How often should my child have a bowel movement?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462784497\">",
"      How will I know if my child is constipated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462784504\">",
"      What if my child gets constipated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462784511\">",
"      When should I take my child to the doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H462784518\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15387\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/61/29661\">",
"      Amount of fiber in different foods",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/7/15477?source=related_link\">",
"      Patient information: Constipation in infants and children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/5/9299?source=related_link\">",
"      Patient information: Diarrhea in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/34/34338?source=related_link\">",
"      Patient information: Diarrhea in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?26/59/27570?source=related_link\">",
"      Patient information: Fecal incontinence in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?25/24/25986?source=related_link\">",
"      Patient information: Stomach ache and stomach upset (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_2_43042="Local reactions to IFA stings";
var content_f42_2_43042=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F56561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F56561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Stinging fire ant and local reactions to stings",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Figure A depicts a stinging fire ant (S. invicta). Figures B, C, and D reveal the different local reactions that can occur following a sting. Figure B reveals several wheal-and-flare reactions (arrows), which may occur within minutes after the sting. Figures C and D show a sterile pustule and cutaneous late-phase allergic reaction with an excoriated sterile pustule, respectively.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kemp SF, deShazo RD, et al. Expanding habitat of the imported fire ant (Solenopsis invicta): A public health concern. J Allergy Clin Immunology 2000; 105:685. Copyright &copy;2000 The American Academy of Allergy, Asthma and Immunology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43042=[""].join("\n");
var outline_f42_2_43042=null;
var title_f42_2_43043="Ticarcillin and clavulanate potassium: Patient drug information";
var content_f42_2_43043=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ticarcillin and clavulanate potassium: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/45/42710?source=see_link\">",
"     see \"Ticarcillin and clavulanate potassium: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/6/35941?source=see_link\">",
"     see \"Ticarcillin and clavulanate potassium: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F227693\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Timentin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F227694\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Timentin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ticarcillin, clavulanate potassium, any penicillin, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015691\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015693\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015688\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015694\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699187",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to store closely.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015695\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11339 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-3918385851-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43043=[""].join("\n");
var outline_f42_2_43043=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227693\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F227694\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015686\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015685\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015690\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015691\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015693\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015688\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015689\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015694\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015695\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?41/45/42710?source=related_link\">",
"      Ticarcillin and clavulanate potassium: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/6/35941?source=related_link\">",
"      Ticarcillin and clavulanate potassium: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_2_43044="Shoulder anat lateral PI";
var content_f42_2_43044=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F53479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F53479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 528px\">",
"   <div class=\"ttl\">",
"    Lateral view of shoulder anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 508px; height: 510px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43044=[""].join("\n");
var outline_f42_2_43044=null;
var title_f42_2_43045="Pemphigus erythematosus";
var content_f42_2_43045=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87180&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87180&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Pemphigus erythematosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     Erosions are on the malar region of the face.",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43045=[""].join("\n");
var outline_f42_2_43045=null;
var title_f42_2_43046="Sixth cranial nerve (abducens nerve) palsy in children";
var content_f42_2_43046=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Sixth cranial nerve (abducens nerve) palsy in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43046/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43046/contributors\">",
"     Andrew G Lee, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43046/contributors\">",
"     Paul W Brazis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43046/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43046/contributors\">",
"     Evelyn A Paysse, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43046/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43046/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43046/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/2/43046/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysfunction of the sixth cranial nerve (abducens nerve) can result from lesions occurring anywhere along its path between the sixth nucleus in the dorsal pons and the lateral rectus muscle within the orbit. The lesions can be congenital or acquired (",
"    <a class=\"graphic graphic_table graphicRef80526 \" href=\"mobipreview.htm?42/39/43645\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The manifestations and diagnosis of sixth nerve palsy, also known as lateral rectus palsy and abducens nerve palsy, are reviewed here. Palsies of the third and fourth cranial nerves are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/34/40487?source=see_link\">",
"     \"Third cranial nerve (oculomotor nerve) palsy in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/44/12999?source=see_link\">",
"     \"Fourth cranial nerve (trochlear nerve) palsy in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each sixth nerve nucleus in the dorsal pons contains all of the neurons responsible for ipsilateral horizontal gaze. They include the motor neurons for the ipsilateral lateral rectus muscle and the interneurons to the contralateral third nerve medial rectus muscle subnucleus in the midbrain. The interneurons travel through the medial longitudinal fasciculus (MLF) to the contralateral third nerve subnucleus.",
"   </p>",
"   <p>",
"    The sixth nerve fascicle leaves the nucleus and travels within the substance of the pontine tegmentum, adjacent to the medial lemniscus and adjacent to the corticospinal tract. It leaves the brainstem at the pontomedullary junction, enters the subarachnoid space (prepontine cistern), courses nearly vertically along the clivus, and travels over the petrous apex of the temporal bone where it is tethered at the petroclinoid ligament in Dorello canal. It enters the substance of the cavernous sinus lateral to the internal carotid artery and medial to the ophthalmic division of the trigeminal nerve. The sixth nerve enters the orbit via the superior orbital fissure to innervate the lateral rectus muscle, which abducts the eye (",
"    <a class=\"graphic graphic_table graphicRef72952 \" href=\"mobipreview.htm?37/58/38827\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with sixth nerve palsies typically complain of binocular (ie, requires both eyes to be open) horizontal diplopia that worsens with gaze toward the paretic lateral rectus muscle. However, children may not complain of diplopia.",
"   </p>",
"   <p>",
"    Early in the course, strabismus may be present only in the gaze toward the paralyzed side, but with time, the strabismus (ie, esotropia) may be present when gazing straight ahead (in primary position). The degree of esotropia and abduction deficit are markers of severity of the paresis or palsy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41800?source=see_link\">",
"     \"Causes of horizontal strabismus in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ocular examination typically reveals a primary position esotropia (eye turned in), worse in gaze toward the paretic muscle (lateral incomitance), and an ipsilateral abduction deficit. The face often is turned toward the paralyzed side to avoid the gaze toward the symptomatic lateral rectus muscle. Other manifestations depend upon the location of the lesion along the course of the nerve (",
"    <a class=\"graphic graphic_table graphicRef55159 \" href=\"mobipreview.htm?18/15/18684\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nuclear lesions result in an ipsilateral horizontal gaze palsy rather than an isolated abduction deficit alone because of involvement of the interneurons of the MLF. These interneurons control contralateral medial rectus function (adduction) during attempted ipsilateral horizontal gaze. Ipsilateral facial nerve palsy may occur because of the close proximity of the facial and abducens nerves in the pons. Nuclear and fascicular lesions usually are associated with other brainstem signs (eg, hemiparesis, hemisensory loss, central Horner syndrome).",
"     </li>",
"     <li>",
"      Lesions of the subarachnoid space can result in unilateral or bilateral sixth nerve palsies. A sixth nerve palsy can occur in these patients as a nonlocalizing sign of increased intracranial pressure (ICP), due to traction of the sixth nerve. The sixth nerve is particularly susceptible to this phenomenon because of its long course within the subarachnoid space. Other neurologic symptoms (eg, headache, nausea, vomiting) and signs (eg, dorsal midbrain syndrome, papilledema) of increased ICP also may be present. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44633?source=see_link\">",
"       \"Elevated intracranial pressure in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lesions of the petrous apex often cause facial pain and damage to the fifth, seventh, and eighth cranial nerves in addition to the sixth nerve.",
"     </li>",
"     <li>",
"      Cavernous sinus lesions often damage the adjacent third, fourth, and fifth (subdivisions one and two) cranial nerves or may cause an ipsilateral Horner syndrome. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23145?source=see_link&amp;anchor=H2#H2\">",
"       \"Septic dural sinus thrombosis\", section on 'Septic cavernous sinus thrombosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lesions of the orbit are associated with other orbital signs, such as proptosis or chemosis (conjunctival swelling), or may produce compressive optic neuropathy (with or without optic disc edema).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sixth nerve palsy may be due to a number of causes (",
"    <a class=\"graphic graphic_table graphicRef80526 \" href=\"mobipreview.htm?42/39/43645\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/2-8\">",
"     2-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dysfunction of the sixth cranial nerve (abducens nerve) can result from lesions occurring anywhere along its path between the sixth nucleus in the dorsal pons to the lateral rectus muscle within the orbit. The lesions can be congenital or acquired.",
"   </p>",
"   <p>",
"    Tumors can compress the sixth nerve anywhere along its path. Elevated ICP produces a sixth nerve palsy by causing pressure or traction of the nerve at the skull base. Inflammatory and infectious (eg, meningitis) disorders tend to affect the sixth nerve in the subarachnoid space. Traumatic sixth nerve palsies often are associated with fractures of the base of the skull. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/24/13704?source=see_link\">",
"     \"Skull fractures in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most common causes of sixth nerve palsy in children are tumors, trauma, increased ICP, and congenital. One study reviewed the causes of sixth nerve palsies in 75 children with an average age of eight years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/1\">",
"     1",
"    </a>",
"    ]. Neoplasms or their neurosurgical removal was the most common cause, accounting for 34 cases (45 percent). The most common tumors were posterior fossa medulloblastoma and brainstem glioma. Other causes included elevated ICP (pseudotumor cerebri) (15 percent), trauma (12 percent), congenital (11 percent), inflammatory (7 percent), miscellaneous (5 percent), and idiopathic (5 percent). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/23/41332?source=see_link\">",
"     \"Histopathology and molecular pathogenesis of medulloblastoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/40/40585?source=see_link\">",
"     \"Focal brainstem glioma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/0/17417?source=see_link\">",
"     \"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of sixth nerve palsy includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Restrictive orbitopathies",
"     </li>",
"     <li>",
"      Spasm of the near reflex",
"     </li>",
"     <li>",
"      Myasthenia gravis",
"     </li>",
"     <li>",
"      Supranuclear disorders of gaze",
"     </li>",
"     <li>",
"      Childhood esotropia",
"     </li>",
"     <li>",
"      Duane syndrome 1",
"     </li>",
"     <li>",
"      Thyroid eye disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Restrictive abduction defects can be produced by orbital floor fracture, orbital tumors or orbital pseudotumor, and thyroid ophthalmopathy. Patients with restrictive orbital disease usually demonstrate proptosis, chemosis (conjunctival edema), conjunctival injection, and positive forced ductions (restrictive findings on passive movement of the globe with ophthalmic forceps). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/35/9783?source=see_link\">",
"     \"Orbital fractures\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/22/3432?source=see_link\">",
"     \"Pathogenesis and clinical features of Graves' ophthalmopathy (orbitopathy)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Spasm of the near reflex (eg, convergence spasm) is associated with a variable esotropia (turning in of the eyes) and abduction deficit with miosis (constriction) of the pupil. The finding of intense miosis on attempted lateral gaze is an important clue to making the correct diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. Spasm of the near reflex usually is a nonorganic finding but rarely may be caused by an organic intracranial process.",
"   </p>",
"   <p>",
"    Myasthenia gravis should be considered in any painless, pupil-sparing ophthalmoplegia, including sixth nerve palsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. Additional signs and symptoms of myasthenia gravis, such as ptosis, variability, and fatigue, usually are present. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/51/17206?source=see_link\">",
"     \"Clinical manifestations of myasthenia gravis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Paralysis of ocular movements also occurs with supranuclear paralyses. In contrast to patients with sixth nerve palsy, patients who have supranuclear disorders of gaze do not have diplopia because the eyes remain parallel. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/8/28806?source=see_link\">",
"     \"Supranuclear disorders of gaze in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of infants and children with sixth nerve palsy depends upon whether the palsy is isolated or accompanied by other neurologic abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/14,16,17\">",
"     14,16,17",
"    </a>",
"    ]. The initial history and physical examination should focus on this distinction and should include the following components:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Is the palsy isolated neurologically?",
"     </li>",
"     <li>",
"      Does the patient have a history of trauma?",
"     </li>",
"     <li>",
"      Are symptoms and signs of increased ICP (eg, headache, nausea, vomiting, papilledema, involvement of other cranial nerves) present?",
"     </li>",
"     <li>",
"      Is the neurologic examination normal?",
"     </li>",
"     <li>",
"      Does the child have focal hemispheric signs (eg, aphasia and hemianopsia)?",
"     </li>",
"     <li>",
"      Does the child have posterior fossa signs (eg, nystagmus, ataxia, and facial palsy)?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Isolated palsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated sixth nerve palsies in children may be congenital, traumatic, postviral, and idiopathic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/1,17,18\">",
"     1,17,18",
"    </a>",
"    ]. Malignancy occasionally can present with an isolated sixth nerve palsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants with congenital sixth nerve palsy usually require evaluation for other associated central nervous system abnormalities (eg, facial nerve palsy, brainstem lesions). Neuroimaging may be necessary depending upon the associated neurologic features.",
"     </li>",
"     <li>",
"      Children who have sixth nerve palsies in the setting of significant head trauma or motor vehicle accident usually undergo neuroimaging at the time of initial injury. Children who develop a sixth nerve palsy in the setting of minor head trauma also should undergo neuroimaging because sixth nerve palsy may be the presenting manifestation of a skull-based neoplasm. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23178?source=see_link\">",
"       \"Approach to neuroimaging in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Benign, isolated sixth nerve palsy may occur after a viral illness [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/17\">",
"       17",
"      </a>",
"      ]. The condition may recur, but the diagnosis of recurrent postviral sixth nerve palsy should be considered a diagnosis of exclusion. Other etiologies, including infectious, inflammatory, and neoplastic causes, must be excluded [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/19\">",
"       19",
"      </a>",
"      ]. Depending upon the clinical setting, these entities typically are evaluated by neuroimaging and cerebrospinal fluid analysis.",
"     </li>",
"     <li>",
"      Malignancy occasionally can present with an isolated sixth nerve palsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/13\">",
"       13",
"      </a>",
"      ]. For this reason, many authorities recommend the use of neuroimaging in all children with acute and chronic sixth nerve palsies. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Neuroimaging'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Nonisolated palsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonisolated sixth nerve palsy may be caused by supranuclear lesions or lesions of the nucleus, subarachnoid space, petrous apex, cavernous sinus, or orbit. Nonisolated sixth nerve palsy may be the presenting, and occasionally only, sign of increased ICP. Other signs and symptoms of elevated ICP, such as papilledema (",
"    <a class=\"graphic graphic_picture graphicRef50378 \" href=\"mobipreview.htm?30/30/31215\">",
"     picture 1",
"    </a>",
"    ), headache, nausea, and vomiting, should be sought actively in these patients. A lumbar puncture may need to be performed if patients are suspected of having meningitis or pseudotumor cerebri. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Clinical manifestations'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/0/17417?source=see_link\">",
"     \"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/8/28810?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     NEUROIMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroimaging is indicated to exclude occult neoplasm in patients with nonneurologically isolated palsies, bilateral, progressive, unresolved, or chronic sixth nerve palsy (a nonresolving palsy that persists beyond 6 to 12 weeks). The imaging (eg, computed tomography) should be performed emergently when focal signs or papilledema are present. Magnetic resonance imaging with gadolinium is the preferred modality because of superior capability of imaging of the posterior fossa, but it may not be available on an emergent basis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23178?source=see_link\">",
"     \"Approach to neuroimaging in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment for sixth cranial nerve palsy depends upon the underlying cause. Children with infectious, inflammatory, or neoplastic lesions should receive appropriate therapy for the underlying condition. Such treatment may alleviate diplopia. Spontaneous recovery is common in patients with unilateral, isolated, nontraumatic sixth nerve palsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/20\">",
"     20",
"    </a>",
"    ]. Symptomatic patients with isolated congenital or acquired palsies should be considered for treatment. The goal is to maximize visual function, including alignment.",
"   </p>",
"   <p>",
"    Traumatic sixth nerve palsy may resolve spontaneously. Spontaneous recovery occurs more commonly in unilateral than in bilateral cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/18,21,22\">",
"     18,21,22",
"    </a>",
"    ]. Thus, patients with traumatic sixth nerve palsy usually are observed for several months before treatment is considered. Inability to abduct past midline (complete palsy) and bilateral involvement at the time of presentation is associated with failure to recover by six months after injury, with or without therapy (prism, patch, or botulinum) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/23\">",
"     23",
"    </a>",
"    ]. Palsies that do not resolve tend to become comitant deviations. Comitant deviations are those in which the distance between the double images is equal in the various gaze directions and symptoms are affected only slightly by the direction of gaze.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Treatment modalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment modalities may include alternate patching, prism therapy, strabismus surgery,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    botulinum toxin.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alternate patching &mdash; Alternate patching of each eye alleviates binocular diplopia in children with sixth nerve palsy. Alternate patching is useful in children who are being observed or who defer treatment with prisms or surgery. Patching in children younger than nine years of age should be employed with caution and with the assistance of an ophthalmology consultant, because complete full-time occlusion of a single eye can lead to the development of iatrogenic (occlusion) amblyopia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/61/8153?source=see_link&amp;anchor=H2#H2\">",
"       \"Overview of amblyopia\", section on 'Definition'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Prism therapy &mdash; Prism therapy may be employed for small, comitant, long-standing deviations. A temporary press-on (Fresnel) prism of sufficient power to align the eyes is placed on the spectacle lens of the affected child. Permanent prisms can be ground into the spectacle lens if the patient is happy with the result and the deviation fails to improve spontaneously.",
"     </li>",
"     <li>",
"      Strabismus surgery &mdash; Strabismus surgery may be helpful in patients who fail prism therapy. In one study of 64 children 7 years of age or younger with sixth nerve palsy of varying etiologies, approximately one-quarter underwent strabismus surgery; residual strabismus was present in 66 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Botulinum toxin &mdash; Botulinum toxin, a neurotoxin that causes temporary muscle paralysis, has been used in patients with acute unilateral sixth nerve palsy. It is injected into the ipsilateral medial rectus muscle (the antagonist of the lateral rectus) to prevent secondary contracture and to reduce the nasal deviation. In one prospective, randomized trial in adults with acute unilateral sixth nerve palsy of various etiologies, recovery rates were similar between the treatment and control groups",
"      <span class=\"nowrap\">",
"       (19/22",
"      </span>",
"      [86 percent] versus",
"      <span class=\"nowrap\">",
"       20/25",
"      </span>",
"      [80 percent], respectively) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/25\">",
"       25",
"      </a>",
"      ]. Randomized controlled trials have not been performed in children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/26\">",
"       26",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Botulinum toxin has been useful in the management of chronic sixth nerve palsy in some patients in uncontrolled studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43046/abstract/27,28\">",
"       27,28",
"      </a>",
"      ]. It appears to work best when used in conjunction with strabismus surgery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with sixth nerve palsies complain of binocular horizontal diplopia that worsens with gaze toward the paretic lateral rectus muscle. Children, however, may not complain of diplopia. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Examination reveals a primary position esotropia worse in gaze toward the paretic muscle (lateral incomitance) and an ipsilateral abduction deficit. Other manifestations depend upon the location of the lesion along the course of the nerve. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sixth nerve palsy has multiple potential causes (",
"      <a class=\"graphic graphic_table graphicRef80526 \" href=\"mobipreview.htm?42/39/43645\">",
"       table 1",
"      </a>",
"      ). The most common causes in children are tumors, trauma, increased ICP, and congenital. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis includes restrictive orbitopathies, spasm of the near reflex, myasthenia gravis, supranuclear disorders of gaze, childhood esotropia, Duane syndrome 1, and thyroid eye disease. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The evaluation of infants and children with sixth nerve palsy depends upon whether the palsy is isolated or accompanied by other neurologic abnormalities. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Isolated sixth nerve palsies may be congenital, traumatic, postviral, and idiopathic. Malignancy occasionally can present with an isolated sixth nerve palsy. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Isolated palsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nonisolated sixth nerve palsy may be caused by supranuclear lesions or lesions of the nucleus, subarachnoid space, petrous apex, cavernous sinus, or orbit. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Nonisolated palsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neuroimaging is indicated to exclude occult neoplasm in patients with nonisolated palsies, bilateral, progressive, or nonresolving palsy that persists beyond 6 to 12 weeks. Imaging should be performed emergently when focal signs or papilledema are present. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Neuroimaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment for sixth cranial nerve palsy depends upon the underlying cause. The goal is to maximize visual function, including alignment. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment modalities may include alternate patching, prism therapy, strabismus surgery,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      botulinum toxin. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Treatment modalities'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/1\">",
"      Lee MS, Galetta SL, Volpe NJ, Liu GT. Sixth nerve palsies in children. Pediatr Neurol 1999; 20:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/2\">",
"      Currie J, Lubin JH, Lessell S. Chronic isolated abducens paresis from tumors at the base of the brain. Arch Neurol 1983; 40:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/3\">",
"      Dumas S, Shults WT. Abducens paresis. A rare presenting sign of posterior-inferior cerebellar artery aneurysm. J Clin Neuroophthalmol 1982; 2:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/4\">",
"      Gurinsky JS, Quencer RM, Post MJ. Sixth nerve ophthalmoplegia secondary to a cavernous sinus lesion. J Clin Neuroophthalmol 1983; 3:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/5\">",
"      Moster ML, Savino PJ, Sergott RC, et al. Isolated sixth-nerve palsies in younger adults. Arch Ophthalmol 1984; 102:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/6\">",
"      RUCKER CW. Paralysis of the third, fourth and sixth cranial nerves. Am J Ophthalmol 1958; 46:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/7\">",
"      Rucker CW. The causes of paralysis of the third, fourth and sixth cranial nerves. Am J Ophthalmol 1966; 61:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/8\">",
"      Rush JA, Younge BR. Paralysis of cranial nerves III, IV, and VI. Cause and prognosis in 1,000 cases. Arch Ophthalmol 1981; 99:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/9\">",
"      Rosenberg ML. Spasm of the near reflex mimicking myasthenia gravis. J Clin Neuroophthalmol 1986; 6:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/10\">",
"      Nirankari VS, Hameroff SB. Spasm of the near reflex. Ann Ophthalmol 1980; 12:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/11\">",
"      Griffin JF, Wray SH, Anderson DP. Misdiagnosis of spasm of the near reflex. Neurology 1976; 26:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/12\">",
"      Goldstein JH, Schneekloth BB. Spasm of the near reflex: a spectrum of anomalies. Surv Ophthalmol 1996; 40:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/13\">",
"      Galetta SL, Smith JL. Chronic isolated sixth nerve palsies. Arch Neurol 1989; 46:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/14\">",
"      Savino PJ, Hilliker JK, Casell GH, Schatz NJ. Chronic sixth nerve palsies. Are they really harbingers of serious intracranial disease? Arch Ophthalmol 1982; 100:1442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/15\">",
"      Kim JH, Hwang JM, Hwang YS, et al. Childhood ocular myasthenia gravis. Ophthalmology 2003; 110:1458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/16\">",
"      Savino PJ. Diplopia and sixth nerve palsies. Semin Neurol 1986; 6:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/17\">",
"      Werner DB, Savino PJ, Schatz NJ. Benign recurrent sixth nerve palsies in childhood. Secondary to immunization or viral illness. Arch Ophthalmol 1983; 101:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/18\">",
"      Mutyala S, Holmes JM, Hodge DO, Younge BR. Spontaneous recovery rate in traumatic sixth-nerve palsy. Am J Ophthalmol 1996; 122:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/19\">",
"      Mahoney NR, Liu GT. Benign recurrent sixth (abducens) nerve palsies in children. Arch Dis Child 2009; 94:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/20\">",
"      King AJ, Stacey E, Stephenson G, Trimble RB. Spontaneous recovery rates for unilateral sixth nerve palsies. Eye (Lond) 1995; 9 ( Pt 4):476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/21\">",
"      Holmes JM, Beck RW, Kip KE, et al. Botulinum toxin treatment versus conservative management in acute traumatic sixth nerve palsy or paresis. J AAPOS 2000; 4:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/22\">",
"      Holmes JM, Droste PJ, Beck RW. The natural history of acute traumatic sixth nerve palsy or paresis. J AAPOS 1998; 2:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/23\">",
"      Holmes JM, Beck RW, Kip KE, et al. Predictors of nonrecovery in acute traumatic sixth nerve palsy and paresis. Ophthalmology 2001; 108:1457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/24\">",
"      Aroichane M, Repka MX. Outcome of sixth nerve palsy or paresis in young children. J Pediatr Ophthalmol Strabismus 1995; 32:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/25\">",
"      Lee J, Harris S, Cohen J, et al. Results of a prospective randomized trial of botulinum toxin therapy in acute unilateral sixth nerve palsy. J Pediatr Ophthalmol Strabismus 1994; 31:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/26\">",
"      Rowe FJ, Noonan CP. Botulinum toxin for the treatment of strabismus. Cochrane Database Syst Rev 2012; 2:CD006499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/27\">",
"      Repka MX, Lam GC, Morrison NA. The efficacy of botulinum neurotoxin A for the treatment of complete and partially recovered chronic sixth nerve palsy. J Pediatr Ophthalmol Strabismus 1994; 31:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43046/abstract/28\">",
"      Holmes JM, Leske DA, Christiansen SP. Initial treatment outcomes in chronic sixth nerve palsy. J AAPOS 2001; 5:370.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6256 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-8C269A7C77-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43046=[""].join("\n");
var outline_f42_2_43046=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Isolated palsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Nonisolated palsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      NEUROIMAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Treatment modalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6256\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6256|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/30/31215\" title=\"picture 1\">",
"      Papilledema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6256|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/39/43645\" title=\"table 1\">",
"      Causes of sixth nerve palsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/58/38827\" title=\"table 2\">",
"      Actions extraocular muscles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/15/18684\" title=\"table 3\">",
"      The localization of abducens nerve lesions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23178?source=related_link\">",
"      Approach to neuroimaging in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41800?source=related_link\">",
"      Causes of horizontal strabismus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/8/28810?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/51/17206?source=related_link\">",
"      Clinical manifestations of myasthenia gravis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44633?source=related_link\">",
"      Elevated intracranial pressure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/40/40585?source=related_link\">",
"      Focal brainstem glioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/44/12999?source=related_link\">",
"      Fourth cranial nerve (trochlear nerve) palsy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/23/41332?source=related_link\">",
"      Histopathology and molecular pathogenesis of medulloblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/0/17417?source=related_link\">",
"      Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/35/9783?source=related_link\">",
"      Orbital fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/61/8153?source=related_link\">",
"      Overview of amblyopia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/22/3432?source=related_link\">",
"      Pathogenesis and clinical features of Graves' ophthalmopathy (orbitopathy)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23145?source=related_link\">",
"      Septic dural sinus thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/24/13704?source=related_link\">",
"      Skull fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/8/28806?source=related_link\">",
"      Supranuclear disorders of gaze in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/34/40487?source=related_link\">",
"      Third cranial nerve (oculomotor nerve) palsy in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_2_43047="Initial management of the critically ill adult with an unknown overdose";
var content_f42_2_43047=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Initial management of the critically ill adult with an unknown overdose",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43047/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43047/contributors\">",
"     Marco L A Sivilotti, MD, MSc, FRCPC, FACEP, FACMT",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43047/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43047/contributors\">",
"     Stephen J Traub, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43047/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43047/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/2/43047/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H7707963\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Poisoning is a leading cause of death in the young, and it is the leading cause of nontraumatic cardiac arrest under the age of 35 years. Overdose is the second leading cause of injury related death in the United States, exceeding the number of deaths due to firearms.",
"   </p>",
"   <p>",
"    Severely poisoned patients may present in extremis. Such patients require an organized, targeted resuscitation despite incomplete, uncertain, or even erroneous information. A &ldquo;generic&rdquo; approach based upon the ACLS protocols intended for cardiac patients is suboptimal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43047/abstract/1\">",
"     1",
"    </a>",
"    ]. It can lead to missed opportunities for specific life-saving interventions and may at times be harmful.",
"   </p>",
"   <p>",
"    This topic will describe an approach to the resuscitation of the critically ill poisoned adult patient when the identity of the agent(s) ingested is initially unknown. The general approach to the poisoned patient and the management of specific poisonings are described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30959739\">",
"    <span class=\"h1\">",
"     INITIAL DATA ACQUISITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Readily available information about the patient and the poisoning may be obtainable from prehospital care providers, other first responders (including witnesses, firemen, police, friends, and family), and from medical records. Medication or chemical product containers, material safety data sheets, pharmacy records, and institutional or patient lists of prescribed medication can be helpful. In addition, the setting and circumstances may help to identify the toxin(s) involved and to prepare interventions. As examples, misadventures with recreational drugs of abuse or accidental industrial exposures suggest the need to prepare for multiple victims, whereas a person who rapidly decompensates after being taken into police custody may have &ldquo;stuffed&rdquo; (ie, swallowed) large amounts of illicit drugs and immediate removal of the leaking package may be life-saving [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43047/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7708001\">",
"    <span class=\"h1\">",
"     FIRST PRIORITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to securing the airway, breathing, and circulation (ABC&rsquo;s) as with any critically ill or injured patient, the resuscitation leader must consider two additional imperatives that may arise with severely poisoned patients: preserving the operational capacity of the emergency health care system and ensuring the safety of health care workers. These priorities are addressed concurrently as part of the primary assessment.",
"   </p>",
"   <p>",
"    Multiple casualty and mass casualty incidents may involve toxic exposures and challenge health care systems of any size. A single patient contaminated with a highly potent toxin (eg, a radioactive isotope or nerve agent such as sarin) can disable an entire emergency department (ED).",
"   </p>",
"   <p>",
"    Rarely, potent agents can directly threaten the health of clinicians when proper protection is not used. Therefore, special care is needed when decontaminating patients with possible toxic exposures. &nbsp;Decontamination should be performed prior to arrival or outside the ED. Soiled clothing and bodily fluids should be placed in appropriate containers and disposed of properly. Decontamination procedures and the chemical and biologic agents likely to be involved in an exposure are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/33/11801?source=see_link\">",
"     \"Topical chemical burns\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/20/8521?source=see_link\">",
"     \"Chemical terrorism: Diagnosis and treatment of exposure to chemical weapons\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/46/22247?source=see_link\">",
"     \"Identifying and managing casualties of biological terrorism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7708012\">",
"    <span class=\"h1\">",
"     RAPID FIRST LOOK: EXAMINATION, MONITORING, AND TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rapid systematic examination should be performed while resuscitative measures are initiated. Several classes of toxins manifest as characteristic combinations of symptoms and signs (so called &ldquo;toxidromes&rdquo;). The &ldquo;toxidrome-oriented&rdquo; physical examination consists of: vital signs; level of alertness; pupil size and position; mucous membranes; skin temperature and moisture; presence or absence of bowel sounds; and assessment of motor tone. Alertness can be categorized simply as alert, responsive to voice, responsive to pain, or unresponsive. The findings of this rapid initial examination may provide valuable insight into the class of toxin involved. The major toxidromes and their associated findings are summarized in the accompanying table (",
"    <a class=\"graphic graphic_table graphicRef71268 \" href=\"mobipreview.htm?43/6/44140\">",
"     table 1",
"    </a>",
"    ). Disturbances in temperature (",
"    <a class=\"graphic graphic_table graphicRef55439 \" href=\"mobipreview.htm?32/12/32973\">",
"     table 2",
"    </a>",
"    ), heart rate and blood pressure (",
"    <a class=\"graphic graphic_table graphicRef51200 \" href=\"mobipreview.htm?29/8/29838\">",
"     table 3",
"    </a>",
"    ), and respiration (",
"    <a class=\"graphic graphic_table graphicRef64012 \" href=\"mobipreview.htm?34/56/35725\">",
"     table 4",
"    </a>",
"    ) can also suggest a toxin class.",
"   </p>",
"   <p>",
"    In addition to the findings above, the clinician should look for signs of trauma (self-inflicted or accidental) or recent intravenous drug use, transdermal patches, and evidence of seizures (eg, incontinence, lateral tongue laceration). Cervical spine precautions may be needed if major trauma is suspected.",
"   </p>",
"   <p>",
"    The clinical team should immediately obtain intravenous access, apply a cardiac monitor, obtain a pulse oximeter reading, and provide high flow oxygen by non-rebreather face mask. The following laboratory tests should be obtained:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Point-of-care capillary blood glucose",
"     </li>",
"     <li>",
"      Complete blood count",
"     </li>",
"     <li>",
"      Basic serum electrolytes, BUN, and creatinine",
"     </li>",
"     <li>",
"      Serum lactate",
"     </li>",
"     <li>",
"      Venous or arterial blood gas, including carboxyhemoglobin and methemoglobin level",
"     </li>",
"     <li>",
"      Serum",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      and salicylate levels",
"     </li>",
"     <li>",
"      Electrocardiogram",
"     </li>",
"     <li>",
"      Other specific drug levels as indicated (eg, ethanol,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/31/30200?source=see_link\">",
"       theophylline",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/27/29113?source=see_link\">",
"       digoxin",
"      </a>",
"      , anti-epileptics)",
"     </li>",
"     <li>",
"      Comprehensive urine drug testing (if available) from a catheterized specimen; do not use intraurethral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      prior to catheterization, as this may mask other substances.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    More detailed information about these initial tests is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30959732\">",
"    <span class=\"h1\">",
"     SYSTEMATIC EVALUATION: THE ABCDE APPROACH",
"    </span>",
"   </p>",
"   <p>",
"    We have adapted the basic ABC (airway, breathing, circulation) approach used in cardiac and trauma resuscitation for the initial management of the critically ill adult with an unknown overdose. The steps are organized according to the issues that pose the most immediate life threats; problems are managed immediately in the order encountered. Important modifications for the poisoned patient are described in each section below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7708035\">",
"    <span class=\"h2\">",
"     &ldquo;A&rdquo;: Airway stabilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who cannot protect their airway should be intubated immediately. One exception is when the clinical scenario suggests opioid overdose; in these cases, administer",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    while assuring adequate oxygen and ventilation. Use small doses initially (eg, 0.05 mg intravenously or 0.1 mg intramuscularly), doubling the dose until reversal of respiratory depression is achieved. Severe hypoglycemia should also be ruled out as a cause of depressed mental status prior to intubation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/51/3897?source=see_link&amp;anchor=H14#H14\">",
"     \"Opioid intoxication in adults\", section on 'Basic measures and antidotal therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Do",
"    <strong>",
"     not",
"    </strong>",
"    administer",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/6/41062?source=see_link\">",
"     flumazenil",
"    </a>",
"    for presumed or known benzodiazepine overdose, as the risk benefit ratio of this agent is poor and withdrawal seizures can develop. The use of flumazenil is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/52/11080?source=see_link&amp;anchor=H14#H14\">",
"     \"Benzodiazepine poisoning and withdrawal\", section on 'Antidote (flumazenil)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Unless the patient is moribund, rapid sequence intubation is the best approach to securing the airway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43047/abstract/3\">",
"     3",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/26/19879?source=see_link\">",
"     Rocuronium",
"    </a>",
"    , in place of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    , is preferred in cases of suspected organophosphate poisoning and acute",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    toxicity. In organophosphate poisoning, succinylcholine may have a markedly prolonged duration of action, as the cholinesterases which degrade it are inactivated by the toxin. Digoxin poisoning may produce hyperkalemia, a contraindication to succinylcholine use. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/25/33176?source=see_link&amp;anchor=H11#H11\">",
"     \"Organophosphate and carbamate poisoning\", section on 'Initial resuscitation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/13/25817?source=see_link&amp;anchor=H14#H14\">",
"     \"Digitalis (cardiac glycoside) poisoning\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with a caustic ingestion who manifest stridor and drooling are ideally intubated early by experienced clinicians using an awake approach. An alternate strategy for securing the airway, and the means to establish a surgical airway if necessary, must be immediately available. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/7/18552?source=see_link&amp;anchor=H21#H21\">",
"     \"The difficult airway in adults\", section on 'Awake technique'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7708061\">",
"    <span class=\"h2\">",
"     &ldquo;B&rdquo;: Breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Administer high-flow oxygen to all critically ill patients with a suspected overdose.",
"   </p>",
"   <p>",
"    Several toxins interfere with oxygenation and ventilation. Carbon monoxide poisoning can cause severe hypoxia despite falsely normal pulse oximetry values. In cases of methemoglobinemia, the pulse oximeter may read around 85 percent despite a visibly cyanotic patient. Other toxicologic causes of cellular hypoxia, despite normal oxygen saturation readings, include cyanide, hydrogen sulfide, and sodium azide. Patients with tissue hypoxia from these toxins require endotracheal intubation and mechanical ventilation using 100 percent oxygen. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/6/10345?source=see_link\">",
"     \"Carbon monoxide poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8729?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of methemoglobinemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/18/7466?source=see_link\">",
"     \"Cyanide poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    poisoning are initially tachypneic and hyperpneic due to the stimulatory effects of aspirin upon the respiratory center of the medulla. This hyperventilation is beneficial and intubation should be avoided if possible because it is difficult to replicate such high minute ventilation with mechanical ventilation. Nevertheless, patients unable to protect their airway must be intubated and hyperventilated. Severe aspirin poisoning can cause precipitous decompensation and death, and such patients require specific and aggressive resuscitation, including treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    and hemodialysis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/28/19913?source=see_link&amp;anchor=H18#H18\">",
"     \"Salicylate (aspirin) poisoning in adults\", section on 'Airway and breathing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with profound metabolic acidosis due to other toxins (eg, methanol, ethylene glycol) can also develop extremely high compensatory minute ventilation. These patients may be acidemic despite a PaCO2 near 10 mmHg. When this high minute ventilation rate slows (eg, due to seizures, fatigue, or iatrogenic sedation or paralysis), the arterial pH falls abruptly, sometimes below 6.8 or 6.9. As such, patients with severe metabolic acidosis due to poisoning are at risk of decompensating rapidly from respiratory failure. Such patients should be intubated for any sign of respiratory failure, either clinically or on blood gas testing. In particular, a relatively normal PaCO2 of 30 to 40 mmHg in the face of a severe metabolic acidosis is evidence of respiratory failure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/3/4154?source=see_link&amp;anchor=H18#H18\">",
"     \"Methanol and ethylene glycol poisoning\", section on 'Airway, breathing, circulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When intubating hyperpneic patients with moderate to severe metabolic acidosis, we suggest the following approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Administer one to three 50 mL amps of 7.5 to 8.4 percent",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"       sodium bicarbonate",
"      </a>",
"      via intravenous bolus before and after intubation.",
"     </li>",
"     <li>",
"      Avoid sedation until just prior to tracheal intubation.",
"     </li>",
"     <li>",
"      Maximize minute ventilation once intubated, while following peak airway pressures and arterial blood gases. Typical initial settings could be 8",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"      at 20 breaths per minute for an adult with moderate acidosis.",
"     </li>",
"     <li>",
"      Organize immediate hemodialysis if a dialyzable toxin (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      , methanol, ethylene glycol) is responsible.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7708080\">",
"    <span class=\"h2\">",
"     &ldquo;C&rdquo;: Circulation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1941839\">",
"    <span class=\"h3\">",
"     Asystole and ventricular fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asystole and ventricular fibrillation are managed according to standard ACLS protocols. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13850?source=see_link&amp;anchor=H8#H8\">",
"     \"Advanced cardiac life support (ACLS) in adults\", section on 'Ventricular fibrillation and pulseless ventricular tachycardia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13850?source=see_link&amp;anchor=H9#H9\">",
"     \"Advanced cardiac life support (ACLS) in adults\", section on 'Asystole and pulseless electrical activity'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1941846\">",
"    <span class=\"h3\">",
"     Hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypotension is treated with a rapid intravenous (IV) infusion of 2 L of isotonic crystalloid, followed by a",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/28/16838?source=see_link\">",
"     norepinephrine",
"    </a>",
"    drip in many cases, pending more specific information to guide therapy. At times, the dose of vasopressor or inotrope needed to achieve a response may be much higher than the usual dose used for non-poisoned patients. Circulatory assist devices (eg, intraaortic balloon pump) and extracorporeal life support (eg, circulatory bypass pump) may be needed in refractory shock.",
"   </p>",
"   <p>",
"    Selected antidotes can be administered empirically to hypotensive patients when circumstances suggest a specific etiology. A list of these antidotes and empirical dosing guidelines are provided (",
"    <a class=\"graphic graphic_table graphicRef66622 \" href=\"mobipreview.htm?40/11/41147\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1941853\">",
"    <span class=\"h3\">",
"     Bradycardia with hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bradycardia with hypotension suggests an overdose with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    , calcium channel blockers, or beta blockers. Digoxin toxicity is characterized by increased automaticity, depressed AV nodal conduction, characteristic repolarization changes, and gastrointestinal symptoms. Beta-blocker toxicity is commonly accompanied by hypoglycemia and, in the case of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    , sodium channel blockade. Overdose with calcium channel blockers usually causes hyperglycemia, while mental status is relatively well preserved. Specific therapy for each agent is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/13/25817?source=see_link\">",
"     \"Digitalis (cardiac glycoside) poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/32/23043?source=see_link\">",
"     \"Dosing regimen for digoxin-specific antibody (Fab) fragments in patients with digoxin toxicity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/63/31736?source=see_link&amp;anchor=H8#H8\">",
"     \"Calcium channel blocker poisoning\", section on 'Management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/19/33081?source=see_link&amp;anchor=H14#H14\">",
"     \"Beta blocker poisoning\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1941860\">",
"    <span class=\"h3\">",
"     Monomorphic, wide-complex tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Monomorphic, wide-complex tachycardia in the setting of poisoning is commonly supraventricular in origin with aberrancy due to sodium channel blockade. Many poisons can cause sodium channel blockade, including tricyclic antidepressants, antihistamines, Type IA antiarrhythmics, and cocaine. The treatment is",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    50 to 100 mEqv given as an intravenous (IV) bolus, and repeated as necessary, until the QRS interval is &lt;100 msec in the limb leads, or until arterial pH approaches 7.55. Other Type I antiarrhythmics (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/34/36391?source=see_link\">",
"     procainamide",
"    </a>",
"    ) should be avoided. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36231?source=see_link&amp;anchor=H15#H15\">",
"     \"Tricyclic antidepressant poisoning\", section on 'Sodium bicarbonate'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43319?source=see_link\">",
"     \"Anticholinergic poisoning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/30/23018?source=see_link\">",
"     \"Cocaine: Acute intoxication\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1941867\">",
"    <span class=\"h3\">",
"     Polymorphic ventricular tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polymorphic ventricular tachycardia (torsade de pointes) is occasionally seen following overdose with Types IA, IC, and III antiarrhythmics;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/43/22199?source=see_link\">",
"     pentamidine",
"    </a>",
"    ; antipsychotics; arsenicals; antifungals; and antihistamines. This arrhythmia is treated with 2 g",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    IV given over two to five minutes. Up to two additional doses may be given as needed. Overdrive pacing with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/31/23029?source=see_link\">",
"     isoproterenol",
"    </a>",
"    or overdrive electrical pacing may also be used. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13850?source=see_link&amp;anchor=H17#H17\">",
"     \"Advanced cardiac life support (ACLS) in adults\", section on 'Irregular wide complex'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1941874\">",
"    <span class=\"h3\">",
"     Narrow complex tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Narrow complex tachycardia and hypertension due to drug overdose or withdrawal are usually due to hyperadrenergic states, as seen with cocaine, amphetamine, and other sympathomimetics. Treatment consists primarily of benzodiazepines, and perhaps",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/43/34485?source=see_link\">",
"     phentolamine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43047/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Refractory hypertension may be treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    (in the setting of cardiac ischemia) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21302?source=see_link\">",
"     nitroprusside",
"    </a>",
"    . Beta-blockers and antipsychotics should be avoided [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43047/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Synchronized cardioversion is rarely effective. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/30/23018?source=see_link&amp;anchor=H9#H9\">",
"     \"Cocaine: Acute intoxication\", section on 'Initial management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/29/474?source=see_link&amp;anchor=H9#H9\">",
"     \"Methamphetamine intoxication\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7708122\">",
"    <span class=\"h2\">",
"     &ldquo;D&rdquo;: Disability and neurological stabilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the airway, breathing, and circulation are secured, attention is next directed towards neurologic stabilization. The so-called &ldquo;coma cocktail&rdquo; of dextrose, oxygen,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    , and thiamine is an outdated concept and has been replaced by selective use of each component as necessary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43047/abstract/8\">",
"     8",
"    </a>",
"    ]. Hypoglycemia can present as",
"    <strong>",
"     any",
"    </strong>",
"    alteration of mental status, including confusion, seizures, focal deficits, and coma. Treat these symptoms with intravenous dextrose when the glucometer reports a low or low-normal capillary blood glucose.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/24/35207?source=see_link\">",
"     Naloxone",
"    </a>",
"    is indicated for the reversal of respiratory depression in the setting of known or suspected opioid toxicity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/51/3897?source=see_link&amp;anchor=H14#H14\">",
"     \"Opioid intoxication in adults\", section on 'Basic measures and antidotal therapy'",
"    </a>",
"    .)",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/6/41062?source=see_link\">",
"     Flumazenil",
"    </a>",
"    should",
"    <strong>",
"     not",
"    </strong>",
"    be used, even when benzodiazepine toxicity is suspected, because it can precipitate benzodiazepine withdrawal, causing seizures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/52/11080?source=see_link&amp;anchor=H14#H14\">",
"     \"Benzodiazepine poisoning and withdrawal\", section on 'Antidote (flumazenil)'",
"    </a>",
"    .) Thiamine may be administered safely before glucose, but is unlikely to reverse coma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43047/abstract/9\">",
"     9",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/27/40372?source=see_link\">",
"     Physostigmine",
"    </a>",
"    is no longer used for its analeptic properties, but does play a role in the management of anticholinergic poisoning. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43319?source=see_link&amp;anchor=H11#H11\">",
"     \"Anticholinergic poisoning\", section on 'Antidotal therapy with physostigmine'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Seizures due to poisoning or withdrawal are best treated with escalating doses of benzodiazepines (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    5 mg IV, repeated and doubled every 5 to 10 minutes as necessary for refractory seizures) (",
"    <a class=\"graphic graphic_table graphicRef54610 \" href=\"mobipreview.htm?28/21/29020\">",
"     table 6",
"    </a>",
"    ).",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    is usually ineffective, and can cause toxicity due to the propylene glycol solvent.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     Propofol",
"    </a>",
"    has superseded the barbiturates and inhalational anesthetics as second-line therapy for benzodiazepine-resistant seizures. When seizures are likely due to sodium channel blockade, intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    should be administered in addition to benzodiazepines. Dosing is described above. (See",
"    <a class=\"local\" href=\"#H7708080\">",
"     '&ldquo;C&rdquo;: Circulation'",
"    </a>",
"    above.) High doses of pyridoxine (5 g IV) should be given to patients in status epilepticus believed to be caused by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    overdose or monomethylhydrazine poisoning (eg, Gyromitra mushrooms). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/1/7191?source=see_link\">",
"     \"Isoniazid (INH) poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Causes other than overdose may be responsible for coma or depressed mental status in the poisoned patient. This is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/9/28825?source=see_link\">",
"     \"Stupor and coma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7708157\">",
"    <span class=\"h2\">",
"     &ldquo;E&rdquo;: Exposure and elimination",
"    </span>",
"    &nbsp;&mdash;&nbsp;This phase of management aims to remove clothing and other external contaminants, to measure core temperature and treat hypothermia or hyperthermia as necessary, to identify self-inflicted or accidental trauma, and to search personal items for concealed drugs, weapons of self-harm, or clues regarding medical history and the nature of the overdose.",
"   </p>",
"   <p>",
"    Severe hyperthermia (greater than 40&deg;C) usually requires paralysis, sedation, and ice bath cooling. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/40/16007?source=see_link&amp;anchor=H10#H10\">",
"     \"Severe hyperthermia (heat stroke) in adults\", section on 'Management'",
"    </a>",
"    .) Severe hypothermia (less than 30&deg;C) is also treated aggressively with rapid rewarming. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/34/15913?source=see_link&amp;anchor=H12#H12\">",
"     \"Accidental hypothermia in adults\", section on 'Management'",
"    </a>",
"    .) Therapeutic hypothermia should be administered to unconscious patients with return of spontaneous circulation after circulatory arrest. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/28/35274?source=see_link&amp;anchor=H9724176#H9724176\">",
"     \"Post-cardiac arrest management in adults\", section on 'Therapeutic (Induced) hypothermia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Methods of enhancing the elimination of poisons, such as gastric lavage,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/52/39750?source=see_link\">",
"     activated charcoal",
"    </a>",
"    , whole bowel irrigation, and hemodialysis, may be helpful for selected patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/58/16297?source=see_link\">",
"     \"Gastrointestinal decontamination of poisoned adults\"",
"    </a>",
"    .) Circumstances may suggest the presence of transdermal medication packages, or concealed drug packages in the GI tract or vagina. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/28/12744?source=see_link\">",
"     \"Internal concealment of drugs of abuse (body packing)\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7708176\">",
"    <span class=\"h1\">",
"     CESSATION OF RESUSCITATIVE EFFORTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unlike most cardiac arrest patients, prolonged resuscitation efforts are not necessarily futile for poisoned patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43047/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. Neurologically intact survival after more than 60 minutes of pulseless arrest and external chest compressions is possible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43047/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. Prolonged resuscitative efforts including extracorporeal circulatory assistance should not be deemed futile for previously healthy patients with witnessed cardiac arrest following drug overdose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43047/abstract/16\">",
"     16",
"    </a>",
"    ]. Even if neurologic recovery is not possible, selected patients poisoned with neurotoxins such as methanol, carbon monoxide, and cyanide can serve as organ donors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7532088\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7708202\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In addition to resuscitation, the clinician managing a critically ill adult with an unknown poisoning must consider two imperatives that may arise with severely poisoned patients: preserving the operational capacity of the emergency health care system and ensuring the safety of health care workers. A single patient contaminated with a highly potent toxin (eg, a radioactive isotope or nerve agent such as sarin) can disable an entire emergency department (ED). (See",
"      <a class=\"local\" href=\"#H7708001\">",
"       'First priorities'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H30959739\">",
"       'Initial data acquisition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A rapid systematic examination is performed while resuscitative measures are initiated. Several classes of toxins manifest as characteristic combinations of symptoms and signs (so called &ldquo;toxidromes&rdquo;) (",
"      <a class=\"graphic graphic_table graphicRef71268 \" href=\"mobipreview.htm?43/6/44140\">",
"       table 1",
"      </a>",
"      ). The &ldquo;toxidrome-oriented&rdquo; physical examination consists of: vital signs; level of alertness; pupil size and position; mucous membranes; skin temperature and moisture; presence or absence of bowel sounds; and assessment of motor tone. Diagnostic tests to be obtained as part of the initial evaluation are described in the text. (See",
"      <a class=\"local\" href=\"#H7708012\">",
"       'Rapid first look: Examination, monitoring, and testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A systematic approach to the resuscitation of the critically ill adult with an unknown overdose, adapted from the basic ABC (airway, breathing, circulation) scheme used for cardiac arrest and trauma patients, is described in the text. The steps are organized according to the issues that pose the most immediate life threats and consist of airway, breathing, circulation, disability (neurologic stabilization), and exposure and elimination. Problems are managed immediately in the order encountered. (See",
"      <a class=\"local\" href=\"#H30959732\">",
"       'Systematic evaluation: The ABCDE approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unlike most cardiac arrest patients, prolonged resuscitation efforts are not necessarily futile for poisoned patients. Neurologically intact survival after more than 60 minutes of pulseless arrest and external chest compressions is possible in some instances. (See",
"      <a class=\"local\" href=\"#H7708176\">",
"       'Cessation of resuscitative efforts'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/1\">",
"      Albertson TE, Dawson A, de Latorre F, et al. TOX-ACLS: toxicologic-oriented advanced cardiac life support. Ann Emerg Med 2001; 37:S78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/2\">",
"      Traub SJ, Hoffman RS, Nelson LS. Body packing--the internal concealment of illicit drugs. N Engl J Med 2003; 349:2519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/3\">",
"      Adnet F, Borron SW, Finot MA, et al. Intubation difficulty in poisoned patients: association with initial Glasgow Coma Scale score. Acad Emerg Med 1998; 5:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/4\">",
"      Burns MJ, Dickson EW, Sivilotti ML, Cuenoud H. Phentolamine reduces myocardial injury and mortality in a rat model of phenylpropanolamine poisoning. J Toxicol Clin Toxicol 2001; 39:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/5\">",
"      Wood DM, Dargan PI, Hoffman RS. Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction. Clin Toxicol (Phila) 2009; 47:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/6\">",
"      Wu S, Pearl-Davis MS, Manini AF, Hoffman RS. Use of antipsychotics to treat cocaine toxicity? Acad Emerg Med 2008; 15:105; author reply 106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/7\">",
"      Hoffman RS. Cocaine and beta-blockers: should the controversy continue? Ann Emerg Med 2008; 51:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/8\">",
"      Hoffman RS, Goldfrank LR. The poisoned patient with altered consciousness. Controversies in the use of a 'coma cocktail'. JAMA 1995; 274:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/9\">",
"      Jackson R, Teece S. Best evidence topic report. Oral or intravenous thiamine in the emergency department. Emerg Med J 2004; 21:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/10\">",
"      Morrison LJ, Verbeek PR, Zhan C, et al. Validation of a universal prehospital termination of resuscitation clinical prediction rule for advanced and basic life support providers. Resuscitation 2009; 80:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/11\">",
"      Kellermann AL, Hackman BB, Somes G. Predicting the outcome of unsuccessful prehospital advanced cardiac life support. JAMA 1993; 270:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/12\">",
"      Bonnin MJ, Pepe PE, Kimball KT, Clark PS Jr. Distinct criteria for termination of resuscitation in the out-of-hospital setting. JAMA 1993; 270:1457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/13\">",
"      Ramsay ID. Survival after imipramine poisoning. Lancet 1967; 2:1308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/14\">",
"      Southall DP, Kilpatrick SM. Imipramine poisoning: survival of a child after prolonged cardiac massage. Br Med J 1974; 4:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/15\">",
"      Orr DA, Bramble MG. Tricyclic antidepressant poisoning and prolonged external cardiac massage during asystole. Br Med J (Clin Res Ed) 1981; 283:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43047/abstract/16\">",
"      International Liaison Committee on Resuscitation. 2005 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Part 4: Advanced life support. Resuscitation 2005; 67:213.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13850 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-65E6C3AFCD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43047=[""].join("\n");
var outline_f42_2_43047=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7708202\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7707963\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30959739\">",
"      INITIAL DATA ACQUISITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7708001\">",
"      FIRST PRIORITIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7708012\">",
"      RAPID FIRST LOOK: EXAMINATION, MONITORING, AND TESTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30959732\">",
"      SYSTEMATIC EVALUATION: THE ABCDE APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7708035\">",
"      &ldquo;A&rdquo;: Airway stabilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7708061\">",
"      &ldquo;B&rdquo;: Breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7708080\">",
"      &ldquo;C&rdquo;: Circulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1941839\">",
"      - Asystole and ventricular fibrillation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1941846\">",
"      - Hypotension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1941853\">",
"      - Bradycardia with hypotension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1941860\">",
"      - Monomorphic, wide-complex tachycardia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1941867\">",
"      - Polymorphic ventricular tachycardia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1941874\">",
"      - Narrow complex tachycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7708122\">",
"      &ldquo;D&rdquo;: Disability and neurological stabilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7708157\">",
"      &ldquo;E&rdquo;: Exposure and elimination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7708176\">",
"      CESSATION OF RESUSCITATIVE EFFORTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7532088\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7708202\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/13850\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/13850|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/6/44140\" title=\"table 1\">",
"      Poisoning syndromes - toxidromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/12/32973\" title=\"table 2\">",
"      Drug and toxin related temperature change",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/8/29838\" title=\"table 3\">",
"      Drug and toxin related pulse changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/56/35725\" title=\"table 4\">",
"      Drug and toxin related respiratory change",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?40/11/41147\" title=\"table 5\">",
"      Empirical dosing of emergency antidotes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/21/29020\" title=\"table 6\">",
"      Drugs that cause seizures",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/34/15913?source=related_link\">",
"      Accidental hypothermia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13850?source=related_link\">",
"      Advanced cardiac life support (ACLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43319?source=related_link\">",
"      Anticholinergic poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/52/11080?source=related_link\">",
"      Benzodiazepine poisoning and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/19/33081?source=related_link\">",
"      Beta blocker poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/63/31736?source=related_link\">",
"      Calcium channel blocker poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/6/10345?source=related_link\">",
"      Carbon monoxide poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/20/8521?source=related_link\">",
"      Chemical terrorism: Diagnosis and treatment of exposure to chemical weapons",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8729?source=related_link\">",
"      Clinical features, diagnosis, and treatment of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/30/23018?source=related_link\">",
"      Cocaine: Acute intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/18/7466?source=related_link\">",
"      Cyanide poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/13/25817?source=related_link\">",
"      Digitalis (cardiac glycoside) poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/32/23043?source=related_link\">",
"      Dosing regimen for digoxin-specific antibody (Fab) fragments in patients with digoxin toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/58/16297?source=related_link\">",
"      Gastrointestinal decontamination of poisoned adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/6/1129?source=related_link\">",
"      General approach to drug poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/46/22247?source=related_link\">",
"      Identifying and managing casualties of biological terrorism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/28/12744?source=related_link\">",
"      Internal concealment of drugs of abuse (body packing)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/1/7191?source=related_link\">",
"      Isoniazid (INH) poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/29/474?source=related_link\">",
"      Methamphetamine intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/3/4154?source=related_link\">",
"      Methanol and ethylene glycol poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/51/3897?source=related_link\">",
"      Opioid intoxication in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/25/33176?source=related_link\">",
"      Organophosphate and carbamate poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/28/35274?source=related_link\">",
"      Post-cardiac arrest management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/55/1912?source=related_link\">",
"      Rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/28/19913?source=related_link\">",
"      Salicylate (aspirin) poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/40/16007?source=related_link\">",
"      Severe hyperthermia (heat stroke) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/9/28825?source=related_link\">",
"      Stupor and coma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/7/18552?source=related_link\">",
"      The difficult airway in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/33/11801?source=related_link\">",
"      Topical chemical burns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36231?source=related_link\">",
"      Tricyclic antidepressant poisoning",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_2_43048="Diagnosis and initial management of cyanotic heart disease in the newborn";
var content_f42_2_43048=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis and initial management of cyanotic heart disease in the newborn",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43048/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43048/contributors\">",
"     Robert L Geggel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43048/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43048/contributors\">",
"     David R Fulton, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43048/contributors\">",
"     Leonard E Weisman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43048/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43048/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/2/43048/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cyanotic lesions comprise approximately one-third of potentially fatal forms of congenital heart disease (CHD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Early recognition, emergent stabilization, and transport to an appropriate cardiac care center are critically important in the outcome of newborns with these lesions.",
"   </p>",
"   <p>",
"    The evaluation and initial management of cyanotic CHD in the newborn are presented here. The causes of neonatal cyanotic cardiac lesions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/56/20359?source=see_link\">",
"     \"Cardiac causes of cyanosis in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87806929\">",
"    <span class=\"h1\">",
"     PRENATAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prenatal sonograms often identify structural malformations including CHD, diaphragmatic hernia, and congenital cystic adenomatoid malformation; however, the sensitivity of CHD detection is highly variable depending on operator expertise, gestational age, fetal position, and type of defect. As a result, prenatal sonography will miss some patients with cyanotic CHD. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/54/4968?source=see_link&amp;anchor=H5#H5\">",
"     \"Prenatal sonographic diagnosis of fetal cardiac anomalies\", section on 'Efficacy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H270524497#H270524497\">",
"     \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'Variability of prenatal ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16848063\">",
"    <span class=\"h1\">",
"     POSTNATAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In affected neonates who are not identified by prenatal sonography, a clinical diagnosis of cyanotic CHD is based on history, physical findings, chest radiography, and hyperoxia test. The diagnosis is confirmed by echocardiography.",
"   </p>",
"   <p>",
"    Central cyanosis caused by reduced arterial oxygen saturation is generally perceptible when the reduced hemoglobin level exceeds 3",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef70325 \" href=\"mobipreview.htm?6/21/6494\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/3\">",
"     3",
"    </a>",
"    ]. It can result from several different pathologic mechanisms that are caused by cardiac disorders, pulmonary abnormalities, or hemoglobinopathies (",
"    <a class=\"graphic graphic_table graphicRef50161 \" href=\"mobipreview.htm?18/6/18540\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/56/20359?source=see_link&amp;anchor=H10#H10\">",
"     \"Cardiac causes of cyanosis in the newborn\", section on 'Etiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/6/17513?source=see_link&amp;anchor=H95089307#H95089307\">",
"     \"Overview of cyanosis in the newborn\", section on 'Hemoglobin concentration'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/6/17513?source=see_link&amp;anchor=H95089279#H95089279\">",
"     \"Overview of cyanosis in the newborn\", section on 'Central cyanosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The more common forms of cyanotic CHD may be clinically distinguished from each other and other causes of central cyanosis based upon the physical examination, chest radiography, and electrocardiography (",
"    <a class=\"graphic graphic_table graphicRef79941 \" href=\"mobipreview.htm?26/1/26653\">",
"     table 2",
"    </a>",
"    ). The hyperoxia test is also used to differentiate cyanotic CHD from cyanosis due to respiratory disease. Echocardiography confirms the diagnosis and determines the underlying cardiac anatomy and function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough history may identify maternal medical or prenatal conditions, or family history of CHD that increases the risk of CHD, and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H353807075#H353807075\">",
"     \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'History'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination may be useful in differentiating CHD from other cyanotic disorders, such as respiratory disease or sepsis that have overlapping clinical findings. Once a cardiac etiology is determined, the examination also provides clues to the underlying specific cardiac defect (",
"    <a class=\"graphic graphic_table graphicRef79941 \" href=\"mobipreview.htm?26/1/26653\">",
"     table 2",
"    </a>",
"    ). The differential diagnosis and the clinical findings that distinguish CHD from other disorders are discussed in the following topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H353807113#H353807113\">",
"     \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'Physical examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/56/20359?source=see_link&amp;anchor=H10#H10\">",
"     \"Cardiac causes of cyanosis in the newborn\", section on 'Etiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following discussion summarizes key findings that are suggestive of CHD",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    specific cardiac lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Vital signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a cyanotic neonate, the pulse, respiratory rate, oxygen saturation, and blood pressure (measured in the right arm and either leg) may be similar between CHD and other causes. In some cases, findings may point to a specific cardiac lesion.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A blood pressure gradient between the arms and legs, or weakened or absent femoral pulses suggests left ventricular dysfunction associated with severe coarctation of the aorta or interrupted aortic arch. If the ductus arteriosus is widely patent, no gradient may be detected between the arms and legs in these disorders.",
"     </li>",
"     <li>",
"      Severe respiratory distress manifested by tachypnea, retractions, and grunting usually indicates a respiratory problem. However, some structural heart diseases can present with similar symptoms. Examples of the latter include obstructed total anomalous pulmonary venous connection and left-sided obstructive disease (eg, hypoplastic left heart, critical valvar aortic stenosis, and severe coarctation of the aorta). Infants with cyanotic CHD usually present with cyanosis with mild or absent tachypnea. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H616124817#H616124817\">",
"       \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'Respiratory abnormalities'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vital signs can be normal in some cyanotic infants with structural heart disease. They may also be normal in polycythemia, pulmonary arteriovenous malformation, or methemoglobinemia.",
"     </li>",
"     <li>",
"      Peripheral cyanosis associated with tachycardia, tachypnea, and hypotension often suggests sepsis. However, it is also important to consider left-heart obstructive lesions with heart failure such as hypoplastic left heart syndrome (HLHS), critical aortic stenosis, and severe coarctation of the aorta in the differential diagnosis of peripheral cyanosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/56/20359?source=see_link&amp;anchor=H22#H22\">",
"       \"Cardiac causes of cyanosis in the newborn\", section on 'Heart failure'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87807098\">",
"    <span class=\"h3\">",
"     Oxygen saturation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cyanotic neonates, transcutaneous oxygen saturation (ie, pulse oximetry) should be measured from preductal (right hand) and postductal sites (right or left foot). Oxygen saturation values are reduced with central cyanosis and usually normal with peripheral cyanosis. A difference in values at the two sites identifies patients with differential cyanosis. In patients with a right aortic arch, the preductal saturation should be measured in the left hand. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/56/20359?source=see_link&amp;anchor=H2#H2\">",
"     \"Cardiac causes of cyanosis in the newborn\", section on 'Definition of cyanosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Second heart sound",
"    </span>",
"    &nbsp;&mdash;&nbsp;The second heard sound (S2) is normally split in inspiration (aortic component before pulmonary component). Splitting is usually audible in 66 percent of infants at 16 hours of age and in 80 percent by 48 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H2707653#H2707653\">",
"     \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'S2 splitting'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the following forms of cyanotic CHD, although potentially difficult to appreciate in a tachycardiac ill neonate, the S2 appears to be single without splitting during auscultation (",
"    <a class=\"graphic graphic_table graphicRef79941 \" href=\"mobipreview.htm?26/1/26653\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In transposition of the great arteries, the pulmonary artery is located posterior and directly behind the aorta. Thus, the aortic component of S2 is loud because of its anterior location and the softer pulmonary component is often inaudible.",
"     </li>",
"     <li>",
"      Pulmonary atresia, truncus arteriosus, or hypoplastic left heart syndrome with aortic atresia have only a single semilunar valve, so S2 has only one component.",
"     </li>",
"     <li>",
"      In tetralogy of Fallot, the diminished pulmonary valve excursion associated with pulmonary stenosis makes the pulmonary component of S2 soft and difficult to detect, especially if there is late peaking of the right ventricular outflow tract systolic murmur. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/27/13752?source=see_link\">",
"       \"Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    S2 is normally split in patients with Ebstein's anomaly of the tricuspid valve and widely split in patients with total anomalous pulmonary venous connection, which is also difficult to appreciate in a tachycardiac ill neonate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Murmur",
"    </span>",
"    &nbsp;&mdash;&nbsp;A pathologic murmur is audible in most common forms of cyanotic CHD (",
"    <a class=\"graphic graphic_table graphicRef79941 \" href=\"mobipreview.htm?26/1/26653\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with Tetralogy of Fallot (TOF) typically have a murmur caused by pulmonary stenosis. TOF associated with pulmonary atresia often has a murmur associated with a patent ductus arteriosus or aortopulmonary collaterals that can be detected as pulmonary vascular resistance falls.",
"     </li>",
"     <li>",
"      A soft, outflow systolic murmur is heard in pulmonary atresia with intact ventricular septum, hypoplastic left heart syndrome, or truncus arteriosus. In all of these lesions, the cardiac output crosses a single semilunar valve, and the volume of blood flow causes the associated murmur. Some patients with truncus arteriosus also have a diastolic murmur of truncal valve regurgitation.",
"     </li>",
"     <li>",
"      Pulmonary atresia is often associated with tricuspid regurgitation. This produces a systolic murmur at the left lower sternal border.",
"     </li>",
"     <li>",
"      Tricuspid atresia is usually associated with a ventricular septal defect and pulmonary stenosis, which creates a systolic murmur.",
"     </li>",
"     <li>",
"      The tricuspid valve in Ebstein's anomaly is nearly always regurgitant and produces a systolic murmur at the left lower sternal border.",
"     </li>",
"     <li>",
"      D-transposition of the great arteries with an intact ventricular septum and no pulmonary stenosis typically has no murmur.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Description of innocent and pathologic murmurs in neonates is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H2707667#H2707667\">",
"     \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'Murmurs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Hepatomegaly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatomegaly often occurs in patients with heart failure due to left-sided obstructive lesions (eg, hypoplastic left heart, coarctation, critical aortic stenosis, and cardiomyopathy) or infradiaphragmatic total anomalous pulmonary venous connection. A palpable liver in the midline suggests complex congenital heart disease (heterotaxy syndromes) associated with asplenia or polysplenia.",
"   </p>",
"   <p>",
"    Some infants with pulmonary disease can appear to have hepatomegaly, but this is caused by displacement by a flattened diaphragm due to hyperinflation. The liver span is not enlarged in these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;A chest radiograph is helpful in differentiating between cardiac and pulmonary disorders. Examination of the lung fields identifies major pulmonary causes of cyanosis including pneumothorax, pulmonary hypoplasia, diaphragmatic hernia, pulmonary edema, pleural effusion, or airway disease.",
"   </p>",
"   <p>",
"    Three features of the chest radiograph that can be suggestive of specific cardiac lesions are heart size or shape, pulmonary vascular markings, and situs of the aortic arch.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Heart size or shape",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Heart size",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Patients with left-sided obstructive lesions may have cardiomegaly due to heart failure.",
"     </li>",
"     <li>",
"      Extreme cardiomegaly suggests lesions associated with a dilated right atrium since this chamber is very compliant. These include pulmonary atresia with intact ventricular septum or Ebstein's anomaly.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Heart shape &ndash; Characteristic abnormalities of heart shape are associated with specific lesions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Tetralogy of Fallot &ndash; Boot-shaped (coeur en sabot) contour (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78997 \" href=\"mobipreview.htm?18/50/19232\">",
"       image 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      D-transposition of the great arteries &ndash; Egg-on-a-string pattern caused by a narrow mediastinal shadow produced by the anterior-posterior rather than right-left relationship of the great arteries.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Pulmonary vascular markings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pattern of pulmonary blood flow depends upon the specific cardiac lesion. Although decreased pulmonary vascular markings occur in most cyanotic CHD lesions, they are increased in patients with truncus arteriosus or mixing lesions, such as common atrioventricular canal, as pulmonary vascular resistance falls after delivery.",
"   </p>",
"   <p>",
"    In D-transposition of the great arteries, vascular markings may be asymmetric. In this condition, the right pulmonary artery branches from the main pulmonary artery along the long-axis of the left ventricle while the left pulmonary artery branches acutely. This anatomy often promotes preferential increased flow to the right lung and asymmetric blood flow with reduced markings in the left lung.",
"   </p>",
"   <p>",
"    Pulmonary venous congestion due to heart failure is characterized by indistinct vascular markings spreading in a butterfly distribution from the central region of the chest. This is often seen in obstructed total anomalous pulmonary venous connection or failure due to left-sided obstructive lesions (hypoplastic left heart syndrome or severe coarctation of the aorta) or cardiomyopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Situs of aortic arch",
"    </span>",
"    &nbsp;&mdash;&nbsp;The situs of the aortic arch is defined by which of the mainstem bronchi the arch crosses. This is best determined by the indentation of the trachea on the anteroposterior image indicating the side to which the aortic arch is coursing towards. The normal anatomy is a left-sided aortic arch with indentation of the left side of the trachea as the arch crosses over the left mainstem bronchus.",
"   </p>",
"   <p>",
"    A right aortic arch results in an indentation on the right side of the trachea. Approximately 20 percent of patients with Tetralogy of Fallot (TOF) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78997 \" href=\"mobipreview.htm?18/50/19232\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/4\">",
"     4",
"    </a>",
"    ], and 30 percent with truncus arteriosus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/5\">",
"     5",
"    </a>",
"    ] have a right aortic arch. Because TOF is much more common than truncus arteriosus, a right aortic arch in a cyanotic infant usually suggests TOF. A right aortic arch may also be associated with other lesions, such as transposition of the great arteries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the fetus, the right ventricle has a larger volume load than the left ventricle since there is limited pulmonary flow and thus reduced blood volume in the left heart. As a result, the normal neonatal electrocardiogram (ECG) has right axis deviation (QRS axis +90 to +180 degrees) and a precordial pattern of right ventricular hypertrophy.",
"   </p>",
"   <p>",
"    Although the ECG may be normal in many cyanotic heart lesions during the neonatal period, some lesions are associated with specific patterns (",
"    <a class=\"graphic graphic_table graphicRef79941 \" href=\"mobipreview.htm?26/1/26653\">",
"     table 2",
"    </a>",
"    ). These include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lesions associated with a small right ventricle have the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Left axis deviation for age (for pulmonary atresia intact ventricular septum typically +30 to +90 degrees; for tricuspid atresia with normally related great arteries typically -30 to -90 degrees)",
"     </li>",
"     <li>",
"      Right atrial enlargement &ndash; Tall peaked P waves most easily identified in lead II",
"     </li>",
"     <li>",
"      Left ventricular hypertrophy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypoplastic left heart syndrome often has marked right ventricular hypertrophy (increased QRS voltage in the right and anterior lead) and decreased left ventricular forces in the lateral precordial leads.",
"     </li>",
"     <li>",
"      Ebstein's anomaly has right atrial enlargement and occasionally a delta wave of Wolff-Parkinson-White syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Hyperoxia test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hyperoxia test is useful in distinguishing cardiac from pulmonary causes of cyanosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In CHD associated with intracardiac right-to-left shunting resulting in cyanosis, blood in the pulmonary veins is fully saturated with oxygen in ambient air. Administering higher concentrations of inspired oxygen increases the amount of dissolved oxygen but has minimal effect on oxygen tension levels because there is no effect on the deoxygenated blood that is shunted to the systemic circulation.",
"     </li>",
"     <li>",
"      In contrast, patients with pulmonary disease have pulmonary venous desaturation. Supplemental oxygen administration in pulmonary disease typically increases pulmonary venous oxygen levels and improves systemic oxygenation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the hyperoxia test, arterial oxygen tension is measured in the right radial artery (preductal) while the patient breathes 100 percent oxygen concentration for 10 minutes. Oxygen can be administered via a hood or endotracheal tube if the patient is already intubated. A significant increase in systemic arterial oxygen saturation and pO2 (above 150 mmHg) during the hyperoxia test makes it more likely that the patient has pulmonary disease. However, failure to increase oxygen saturation and pO2 does not definitively \"rule in\" cyanotic congenital heart disease as severe forms of lung disease or persistent pulmonary hypertension of the newborn may not increase the oxygen saturation and pO2 with the hyperoxic challenge.",
"   </p>",
"   <p>",
"    A transcutaneous oxygen monitor can be used to assess whether arterial oxygen tension rises in response to the increased inspired oxygen concentration, thereby avoiding arterial puncture for blood sampling. However, an abnormal or equivocal response must be verified by measurement of an arterial blood gas. (See",
"    <a class=\"local\" href=\"#H87808016\">",
"     'Arterial blood gas'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/61/29656?source=see_link\">",
"     \"Oxygen monitoring and therapy in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preductal oxygen tension while breathing 100 percent oxygen concentration rarely exceeds 150 mmHg in cyanotic heart disease and usually exceeds this value in pulmonary disease (",
"    <a class=\"graphic graphic_table graphicRef54070 \" href=\"mobipreview.htm?16/41/17053\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/6\">",
"     6",
"    </a>",
"    ]. In these cases, the echocardiography is needed to establish the underlying diagnosis.",
"   </p>",
"   <p>",
"    The level of PaO2 in 100 percent oxygen also helps to distinguish among the types of cyanotic heart disease (",
"    <a class=\"graphic graphic_table graphicRef75461 \" href=\"mobipreview.htm?10/61/11228\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with lesions such as transposition of the great arteries or severe pulmonary outflow obstruction generally have PaO2 &lt;50 to 60 mmHg during the administration of 100 percent oxygen.",
"     </li>",
"     <li>",
"      In contrast, in patients with mixing lesions involving both right-to-left and left-to-right shunting, such as truncus arteriosus or single ventricle with patent ductus arteriosus, the systemic oxygen tension may increase with administration of 100 percent oxygen. In these cases, supplemental oxygen may decrease pulmonary vascular resistance, thereby increasing pulmonary flow. The increased pulmonary flow mixed with a fixed amount of systemic venous return results in increased aortic oxygenation, typically to PaO2 values of 75 to 150 mmHg, but rarely higher [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/6\">",
"       6",
"      </a>",
"      ]. In these patients, the chest radiograph typically demonstrates cardiomegaly and prominent pulmonary vascularity.",
"     </li>",
"     <li>",
"      Increased oxygenation with supplemental oxygen is also seen when pulmonary disease, such as pulmonary edema or pneumonia, is associated with cyanotic CHD. However, the PO2 rarely exceeds 150 mmHg.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A pulse oximeter should",
"    <strong>",
"     not",
"    </strong>",
"    be used for the hyperoxia test because it may not detect an inadequate increase in oxygen tension. Because of the characteristics of the oxygen dissociation curve, normal hemoglobin is fully saturated with oxygen when the arterial PO2 exceeds 70 mmHg (",
"    <a class=\"graphic graphic_figure graphicRef59739 \" href=\"mobipreview.htm?30/36/31310\">",
"     figure 2",
"    </a>",
"    ). Therefore, a patient receiving 100 percent inspired oxygen concentration could have an oxygen saturation of nearly 100 percent associated with an arterial PO2 of 75 mmHg, a value that is abnormal. Thus, discrimination between cardiac mixing lesions and pulmonary disease may be limited. However, pulse oximetry may be helpful if saturation remains less than 93 to 95 percent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/6/17513?source=see_link&amp;anchor=H95089314#H95089314\">",
"     \"Overview of cyanosis in the newborn\", section on 'Fetal hemoglobin'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiography, including imaging, and pulsed and color Doppler interrogation of flow patterns provides a definitive diagnosis of CHD with information on cardiac anatomy and function. Echocardiography should be performed in any newborn with central cyanosis who has failed a hyperoxia test or has an equivocal result. Other indications for echocardiography include blood pressure or pulse differential between upper and lower extremities, cardiomegaly, murmur, or cyanosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16848336\">",
"    <span class=\"h2\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other tests included in the evaluation of a neonate with cyanosis include arterial blood gas, complete blood count, and blood cultures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87808016\">",
"    <span class=\"h3\">",
"     Arterial blood gas",
"    </span>",
"    &nbsp;&mdash;&nbsp;A blood gas measurement on an arterial sample should be obtained in any newborn with cyanosis. An arterial blood gas measurement provides information on the PaO2, PaCO2 (indicative of adequate ventilation), and arterial pH.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An arterial PO2 value provides more specific data than oxygen saturation. Because of the increased affinity of fetal hemoglobin for oxygen, PO2 values at a given level of oxygen saturation are often lower in newborns than adults. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/6/17513?source=see_link&amp;anchor=H95089314#H95089314\">",
"       \"Overview of cyanosis in the newborn\", section on 'Fetal hemoglobin'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An elevated arterial PCO2 value often indicates the presence of pulmonary disease. PCO2 may also be increased in heart failure due to pulmonary congestion.",
"     </li>",
"     <li>",
"      A reduced pH level raises concern about poor cardiac output and pending shock, which can be seen in cases of severe hypoxemia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      heart failure. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/2/39975?source=see_link&amp;anchor=H17#H17\">",
"       \"Etiology, clinical manifestations, and evaluation of neonatal shock\", section on 'Laboratory findings'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with methemoglobinemia typically have low oxygen saturation and normal oxygen tension. In this uncommon condition, the blood has a chocolate-brown color and does not become red when exposed to air (",
"      <a class=\"graphic graphic_figure graphicRef58540 \" href=\"mobipreview.htm?16/60/17344\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16848361\">",
"    <span class=\"h3\">",
"     Complete blood count",
"    </span>",
"    &nbsp;&mdash;&nbsp;Newborns with cyanosis should have a complete blood count and differential analysis, which may help differentiate CHD from noncardiac disorders. As examples, an elevated hematocrit or hemoglobin concentration identifies patients with polycythemia, whereas an elevated or decreased white blood cell count or thrombocytopenia suggests possible sepsis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/6/36968?source=see_link\">",
"     \"Neonatal polycythemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/16/6410?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical features and diagnosis of sepsis in term and late preterm infants\", section on 'Other blood tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16848368\">",
"    <span class=\"h3\">",
"     Sepsis evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because sepsis is a common disorder in the differential diagnosis of cyanotic CHD, a blood culture should be obtained. Urinalysis and urine culture are also usually obtained. Depending upon the level of clinical suspicion, a lumbar puncture should be performed, with analysis and culture of the cerebrospinal fluid. Empirical antibiotics are generally given until culture results are available. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/16/6410?source=see_link&amp;anchor=H22#H22\">",
"     \"Clinical features and diagnosis of sepsis in term and late preterm infants\", section on 'Differential diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/37/26200?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and outcome of sepsis in term and late preterm infants\", section on 'Empiric antibiotic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     INITIAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Newborns with cyanosis require immediate assessment, general supportive care that maintains adequate tissue perfusion and oxygenation, and specific therapy when an underlying cause is known. Specific interventions for neonatal cyanotic CHD include administration of prostaglandin E1 (also referred to as",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?22/57/23445?source=see_link\">",
"     alprostadil",
"    </a>",
"    ) and cardiac catheter palliative or corrective procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     General supportive care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial management begins with general care that includes cardiorespiratory support and monitoring to ensure sufficient",
"    <span class=\"nowrap\">",
"     organ/tissue",
"    </span>",
"    perfusion and oxygenation. If there is respiratory compromise, an adequate airway should be established immediately and supportive therapy (eg, supplemental oxygen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mechanical ventilation) instituted as needed. Patients with hypotension or poor perfusion require cardiopulmonary resuscitation.",
"   </p>",
"   <p>",
"    Vital signs should be monitored and vascular access established for sampling of blood and administration of medications. Placement of secure intravenous and intraarterial catheters is most easily accomplished via the umbilical vessels. This will enable efficient correction and monitoring of acid-base balance, metabolic derangements (eg, hypoglycemia, hypocalcemia), and blood pressure. Inotropic agents such as dopamine or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?24/48/25348?source=see_link\">",
"     dobutamine",
"    </a>",
"    may be necessary to correct hypotension.",
"   </p>",
"   <p>",
"    In infants with severe polycythemia (&gt;70 percent), an isovolumetric partial exchange transfusion should be performed with saline to reduce the hematocrit. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/6/36968?source=see_link\">",
"     \"Neonatal polycythemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If cyanosis is due to acquired methemoglobinemia, the offending agent is removed. In severe cases,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/61/20438?source=see_link\">",
"     methylene blue",
"    </a>",
"    , 1 percent solution, in a dose of 1 to 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    (0.1 to 0.2",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    of a 1 percent solution) is infused intravenously over five to 10 minutes. The dose can be repeated in one hour if needed. Congenital methemoglobinemia does not respond to methylene blue. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8729?source=see_link&amp;anchor=H21#H21\">",
"     \"Clinical features, diagnosis, and treatment of methemoglobinemia\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sepsis can lead to cyanosis and left ventricular dysfunction or pulmonary disease. As a result, unless another specific etiology is promptly identified, broad spectrum antibiotics should be initiated (",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?36/48/37632?source=see_link\">",
"     gentamicin",
"    </a>",
"    ) after obtaining blood and urine cultures. (See",
"    <a class=\"local\" href=\"#H16848368\">",
"     'Sepsis evaluation'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/37/26200?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and outcome of sepsis in term and late preterm infants\", section on 'Empiric antibiotic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87808315\">",
"    <span class=\"h2\">",
"     Specific CHD measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;An infant who fails the hyperoxia test and does not have persistent pulmonary hypertension of the newborn or a chest radiograph consistent with lung disease is likely to have a cyanotic CHD. In most cases, cyanotic CHD is dependent upon a patent ductus arteriosus for pulmonary or systemic blood flow. Closure of the ductus arteriosus can precipitate rapid clinical deterioration with significant life-threatening changes (ie, severe metabolic acidosis, seizures, cardiogenic shock, cardiac arrest, or end-organ injury). As a result, infants with ductal-dependent lesions are at increased risk for death and significant morbidity unless interventions are initiated to maintain patency of the ductus arteriosus for ductal-dependent lesions, ensure adequate mixing of deoxygenated and oxygenated blood, or relieve obstructed blood flow. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H270523895#H270523895\">",
"     \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'Ductal dependent lesions, delayed diagnosis, and death'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H2707589#H2707589\">",
"     \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'Cyanosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Prostaglandin E1",
"    </span>",
"    &nbsp;&mdash;&nbsp;In infants with or who have a clinical suspicion for a ductal-dependent congenital heart defect, prostaglandin E1 (",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?22/57/23445?source=see_link\">",
"     alprostadil",
"    </a>",
"    ) should be administered until a definitive diagnosis or treatment is established.",
"   </p>",
"   <p>",
"    The initial dose is dependent on the clinical setting as the risk of apnea, one of the major complications of prostaglandin E1 infusion, is dose dependent.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the ductus is known to be large in a patient with duct-dependent physiology, the initial dose is 0.01",
"      <span class=\"nowrap\">",
"       &micro;g/kg",
"      </span>",
"      per minute. This scenario typically is seen in patients with echocardiographic confirmation of a large patent ductus arteriosus who are cared for in a tertiary center that provides treatment for neonates with cyanotic heart disease.",
"     </li>",
"     <li>",
"      If the ductus is restrictive or the status of the ductus is unknown, the initial dose is 0.05",
"      <span class=\"nowrap\">",
"       &micro;g/kg",
"      </span>",
"      per minute. This is the standard dose used in patients who require transport to a center with expertise in the care of neonates with cyanotic heart disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The dose of prostaglandin can be increased as needed to a maximum dose of 0.1",
"    <span class=\"nowrap\">",
"     &micro;g/kg",
"    </span>",
"    per minute.",
"   </p>",
"   <p>",
"    Complications of prostaglandin E1 infusion include hypotension, tachycardia, and apnea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/7\">",
"     7",
"    </a>",
"    ]. As a result, a separate reliable intravenous catheter must be in place to provide fluids for resuscitation. Intubation equipment should be immediately available because apnea can occur at any time during infusion.",
"   </p>",
"   <p>",
"    Deterioration of the clinical status after starting prostaglandin E1 usually indicates the presence of rare congenital cardiac defects associated with pulmonary venous or left atrial obstruction. These include obstructive (usually infradiaphragmatic) total anomalous pulmonary venous connection or various conditions associated with a restrictive atrial septum (eg, hypoplastic left heart syndrome, cor triatriatum, severe mitral stenosis or atresia, or D-transposition of the great arteries associated with restrictive atrial shunting). These patients require urgent echocardiography followed by interventional cardiac catheterization or surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Cardiac catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac catheter interventions can either be palliative by improving cyanosis or be corrective by relieving obstruction to flow.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Balloon atrial septostomy can relieve marked cyanosis in patients with D-transposition of the great arteries associated with restrictive atrial shunting, and in patients with a restrictive atrial septum associated with left-sided obstructive disease. In patients with D-transposition of the great arteries, this procedure can be performed at the bedside under echocardiographic guidance. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/59/36793?source=see_link&amp;anchor=H4434705#H4434705\">",
"       \"Management and outcome of D-transposition of the great arteries\", section on 'Balloon atrial septostomy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/27/41401?source=see_link&amp;anchor=H92201257#H92201257\">",
"       \"Hypoplastic left heart syndrome\", section on 'Initial medical management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Balloon valvuloplasty can be effective in patients with critical pulmonary stenosis or aortic stenosis. Selected patients with pulmonary atresia are also candidates for balloon valvuloplasty if the obstruction is membranous, the tricuspid annulus and right ventricular size are adequate to support a two ventricle repair, and if the coronary circulation does not depend upon the right ventricle [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/28/38345?source=see_link&amp;anchor=H18#H18\">",
"       \"Valvar aortic stenosis in children\", section on 'Balloon valvotomy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Transcatheter occlusion of pulmonary arteriovenous malformations can also be performed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87808376\">",
"    <span class=\"h2\">",
"     Transport",
"    </span>",
"    &nbsp;&mdash;&nbsp;When it is necessary to transfer a neonate with cyanotic CHD from the birth hospital to another medical facility with pediatric cardiology expertise, the patient should be intubated and mechanically ventilated prior to and during transport if prostaglandin E1 (",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?22/57/23445?source=see_link\">",
"     alprostadil",
"    </a>",
"    ) is being administered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although an Australian report suggested that transported infants with suspected CHD who receive low-dose of prostaglandin E1 (less than 0.015",
"    <span class=\"nowrap\">",
"     &micro;g/kg/min)",
"    </span>",
"    may not require mechanical ventilation, significant limitations of the study (ie, retrospective nature of the study and the non-systematic use of mechanical ventilation and prostaglandin E1) dictate caution in general application of these results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43048/abstract/11\">",
"     11",
"    </a>",
"    ]. Until controlled trials are performed, we continue to intubate and ventilate all infants prior to transport if they are receiving prostaglandin E1 because they are at-risk for apnea. However, intubation is not routinely performed by all tertiary care transport teams.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/15/242?source=see_link\">",
"       \"Patient information: Total anomalous pulmonary venous connection in children (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/25/2450?source=see_link\">",
"       \"Patient information: Tetralogy of Fallot (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87808491\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cyanotic cardiac lesions account for approximately one-third of potentially fatal cases of CHD.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although prenatal sonograms often identify CHD, the sensitivity of the test is highly variable and depends on operator expertise, gestational age, fetal position, and type of defect. As a result, prenatal sonography will miss some cases with cyanotic CHD. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/54/4968?source=see_link&amp;anchor=H5#H5\">",
"       \"Prenatal sonographic diagnosis of fetal cardiac anomalies\", section on 'Efficacy'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H270524497#H270524497\">",
"       \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'Variability of prenatal ultrasound'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In neonates with cyanotic CHD who are not identified by prenatal sonography, a clinical diagnosis is based on history, physical findings, chest radiography, and hyperoxia test, and confirmed by echocardiography (",
"      <a class=\"graphic graphic_table graphicRef79941 \" href=\"mobipreview.htm?26/1/26653\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16848063\">",
"       'Postnatal diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The history may identify maternal or perinatal conditions and a family history of CHD that are risk factors for CHD. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H353807075#H353807075\">",
"       \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'History'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The physical examination may provide information that differentiates CHD from other cyanotic disorders such as respiratory disease or sepsis, and may also suggest specific cardiac defects (",
"      <a class=\"graphic graphic_table graphicRef79941 \" href=\"mobipreview.htm?26/1/26653\">",
"       table 2",
"      </a>",
"      ). Physical findings associated with CHD include an abnormal heart rate, heart sounds, pathologic murmurs, blood pressure gradient between the upper and lower extremities, and hepatomegaly. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A chest radiograph may help differentiate between cardiac and pulmonary etiologies for neonatal cyanosis. Abnormal findings in the lung fields are indicative of a pulmonary cause, whereas increased heart size, abnormal heart shape, and a right-sided aortic arch are suggestive of CHD. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Chest radiograph'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In a cyanotic infant, the hyperoxia test may be helpful in distinguishing cardiac from pulmonary causes of cyanosis (",
"      <a class=\"graphic graphic_table graphicRef54070 \" href=\"mobipreview.htm?16/41/17053\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef75461 \" href=\"mobipreview.htm?10/61/11228\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Hyperoxia test'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Echocardiography provides a definitive diagnosis of CHD and information on cardiac anatomy and function. Echocardiography should be performed in any newborn with central cyanosis who has failed a hyperoxia test or has an equivocal result. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Echocardiography'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The initial management of newborns with cyanosis includes general supportive care to ensure adequate tissue perfusion and oxygenation.",
"     </li>",
"     <li>",
"      The differential diagnosis for neonatal cyanosis includes sepsis, as a result, we recommend administering empiric antibiotic therapy after obtaining urine and blood cultures in neonates with cyanosis, in whom no underlying cause has been identified (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/16/6410?source=see_link&amp;anchor=H22#H22\">",
"       \"Clinical features and diagnosis of sepsis in term and late preterm infants\", section on 'Differential diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/37/26200?source=see_link&amp;anchor=H4#H4\">",
"       \"Treatment and outcome of sepsis in term and late preterm infants\", section on 'Empiric antibiotic therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In infants with a clinical suspicion for ductal-dependent CHD, we recommend prostaglandin E1 (",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?22/57/23445?source=see_link\">",
"       alprostadil",
"      </a>",
"      ) administration until a definitive diagnosis of a non-ductal dependent lesion is established (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). In patients with ductal-dependent CHD, we recommend prostaglandin E1 administration until corrective treatment is performed. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Prostaglandin E1'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H270523895#H270523895\">",
"       \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'Ductal dependent lesions, delayed diagnosis, and death'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=see_link&amp;anchor=H2707589#H2707589\">",
"       \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'Cyanosis'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      If it is necessary to transfer a neonate with cyanotic CHD who is receiving prostaglandin infusion, the patient should be intubated and mechanically ventilated prior to and during transport because apnea is a known complication of prostaglandin therapy.",
"     </li>",
"     <li>",
"      Cardiac catheter interventions include palliative procedures that reduce cyanosis by improved mixing of oxygenated and deoxygenated blood, or corrective procedures that relieve obstructive blood flow. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Cardiac catheterization'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26467694\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Laurie Armsby, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Duff DF, McNamara DG. History and physical examination of the cardiovascular system. In: The science and practice of pediatric cardiology, Garson A Jr, Bricker TM, Fisher DJ, Neish SR (Eds), Williams and Wilkins, Baltimore 1998. p.693.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43048/abstract/2\">",
"      Report of the New England Regional Infant Cardiac Program. Pediatrics 1980; 65:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43048/abstract/3\">",
"      Lees MH. Cyanosis of the newborn infant. Recognition and clinical evaluation. J Pediatr 1970; 77:484.",
"     </a>",
"    </li>",
"    <li>",
"     Zuberbuhler JR. Tetralogy of Fallot. In: Heart disease in infants, children, and adolescents, 5th, Emmanouilides GC, Riemenschneider TA, Allen HD, Getgesell HP (Eds), Williams and Wilkins, Baltimore 1995. p.998.",
"    </li>",
"    <li>",
"     Mair DD, Edwards WD, Julsrud PR, et al. Truncus arteriosus. In: Heart disease in infants, children, and adolescents, 5th, Emmanouilides GC, Riemenschneider TA, Allen HD, Getgesell HP (Eds), Williams and Wilkins, Baltimore 1995. p.1026.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43048/abstract/6\">",
"      Jones RW, Baumer JH, Joseph MC, Shinebourne EA. Arterial oxygen tension and response to oxygen breathing in differential diagnosis of congenital heart disease in infancy. Arch Dis Child 1976; 51:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43048/abstract/7\">",
"      Lewis AB, Freed MD, Heymann MA, et al. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 1981; 64:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43048/abstract/8\">",
"      Marino BS, Bird GL, Wernovsky G. Diagnosis and management of the newborn with suspected congenital heart disease. Clin Perinatol 2001; 28:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43048/abstract/9\">",
"      Cheatham JP. The transcatheter management of the neonate and infant with pulmonary atresia and intact ventricular septum. J Interven Cardiol 1998; 11:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43048/abstract/10\">",
"      Fletcher SE, Cheatham JP, Bolam DL. Primary transcatheter treatment of congenital pulmonary arteriovenous malformation causing cyanosis of the newborn. Catheter Cardiovasc Interv 2000; 50:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43048/abstract/11\">",
"      Browning Carmo KA, Barr P, West M, et al. Transporting newborn infants with suspected duct dependent congenital heart disease on low-dose prostaglandin E1 without routine mechanical ventilation. Arch Dis Child Fetal Neonatal Ed 2007; 92:F117.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5785 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-6FA69E1D15-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43048=[""].join("\n");
var outline_f42_2_43048=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H87808491\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H87806929\">",
"      PRENATAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16848063\">",
"      POSTNATAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Vital signs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H87807098\">",
"      - Oxygen saturation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Second heart sound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Murmur",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Hepatomegaly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Heart size or shape",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Pulmonary vascular markings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Situs of aortic arch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Hyperoxia test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16848336\">",
"      Other tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H87808016\">",
"      - Arterial blood gas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16848361\">",
"      - Complete blood count",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16848368\">",
"      - Sepsis evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      INITIAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      General supportive care",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H87808315\">",
"      Specific CHD measures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Prostaglandin E1",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H87808376\">",
"      Transport",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H87808491\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26467694\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5785\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5785|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?18/50/19232\" title=\"diagnostic image 1\">",
"      Chest xray tetralogy Fallot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5785|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?6/21/6494\" title=\"figure 1\">",
"      Cyanosis and Hgb concentration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?30/36/31310\" title=\"figure 2\">",
"      Factors affecting neonatal oxygen dissociation curve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?16/60/17344\" title=\"figure 3\">",
"      Acquired methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5785|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/6/18540\" title=\"table 1\">",
"      Causes central cyanosis newborn",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/1/26653\" title=\"table 2\">",
"      Findings cyanotic heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/41/17053\" title=\"table 3\">",
"      Interpretation neonatal hyperoxia test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/61/11228\" title=\"table 4\">",
"      PaO2 in cyanotic heart disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/56/20359?source=related_link\">",
"      Cardiac causes of cyanosis in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/16/6410?source=related_link\">",
"      Clinical features and diagnosis of sepsis in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/33/8729?source=related_link\">",
"      Clinical features, diagnosis, and treatment of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/44/33482?source=related_link\">",
"      Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/2/39975?source=related_link\">",
"      Etiology, clinical manifestations, and evaluation of neonatal shock",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/27/41401?source=related_link\">",
"      Hypoplastic left heart syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/59/36793?source=related_link\">",
"      Management and outcome of D-transposition of the great arteries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/6/36968?source=related_link\">",
"      Neonatal polycythemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/6/17513?source=related_link\">",
"      Overview of cyanosis in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/61/29656?source=related_link\">",
"      Oxygen monitoring and therapy in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/27/13752?source=related_link\">",
"      Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?2/25/2450?source=related_link\">",
"      Patient information: Tetralogy of Fallot (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/15/242?source=related_link\">",
"      Patient information: Total anomalous pulmonary venous connection in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/54/4968?source=related_link\">",
"      Prenatal sonographic diagnosis of fetal cardiac anomalies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/37/26200?source=related_link\">",
"      Treatment and outcome of sepsis in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/28/38345?source=related_link\">",
"      Valvar aortic stenosis in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_2_43049="Alternatives and adjuncts to moderate procedural sedation for gastrointestinal endoscopy";
var content_f42_2_43049=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Alternatives and adjuncts to moderate procedural sedation for gastrointestinal endoscopy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43049/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43049/contributors\">",
"     Jonathan Cohen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43049/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43049/contributors\">",
"     John R Saltzman, MD, FACP, FACG, FASGE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/2/43049/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/2/43049/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/2/43049/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of gastrointestinal endoscopy has greatly expanded the diagnostic and therapeutic capabilities of gastroenterologists. Adequate patient tolerance is essential for successful completion of a safe examination and compliance with subsequent follow-up. As a result, endoscopists have developed skills in administering a variety of sedative and analgesic agents to facilitate procedures and enhance patient comfort.",
"   </p>",
"   <p>",
"    Most of the attention has been placed on selecting the optimal regimen for producing procedural sedation and monitoring patients adequately during the procedures. Many procedures are performed using intravenous benzodiazepines and opiates (previously referred to as intravenous conscious sedation), which typically result in moderate degrees of sedation. More recently, there have been attempts to determine which patients and procedures require deeper sedation. In addition, there has been an effort to make some diagnostic procedures more tolerable to avoid the cost and risk of procedural sedation altogether.",
"   </p>",
"   <p>",
"    Endoscopists occasionally encounter individuals who are difficult or impossible to adequately sedate for endoscopy using standard agents. In addition, certain therapeutic endoscopic procedures require deeper levels of sedation. There are multiple options in these settings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Addition of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"       diphenhydramine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"       droperidol",
"      </a>",
"      to standard procedural sedation",
"     </li>",
"     <li>",
"      Administration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"     </li>",
"     <li>",
"      General anesthesia with endotracheal intubation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review the use of these alternative and adjunctive approaches for sedation for gastrointestinal endoscopy. An overview of procedural sedation for gastrointestinal endoscopy, the complications of sedation, and the performance of endoscopic procedures without sedation are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/22/24936?source=see_link\">",
"     \"Overview of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/41/28310?source=see_link\">",
"     \"Complications of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/44/42694?source=see_link\">",
"     \"Sedation-free gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATIENTS WHO ARE LIKELY TO BE DIFFICULT TO SEDATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Characteristics of patients who are difficult to sedate using standard regimens have not been well established in controlled trials. However, several characteristics are generally considered to be risk factors for difficult sedation, including [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A history of prior difficulty with procedural sedation",
"     </li>",
"     <li>",
"      Prescribed or illicit benzodiazepine or opioid use",
"     </li>",
"     <li>",
"      Heavy alcohol use (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/24/25993?source=see_link&amp;anchor=H114013246#H114013246\">",
"       \"Screening for unhealthy use of alcohol and other drugs\", section on 'Alcohol'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Difficulty with sedation has been observed in up to 30 percent of such patients. Other factors that have been associated with difficult sedation include patient anxiety and procedure duration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/3,5,6\">",
"     3,5,6",
"    </a>",
"    ]. Furthermore, paradoxical agitation in response to benzodiazepines has been well described. Observations by some endoscopists that patients with irritable bowel syndrome and those with suspected biliary dyskinesia (which is usually attributed to sphincter of Oddi dysfunction) are more difficult to sedate and require higher doses of medication to complete an examination remain untested.",
"   </p>",
"   <p>",
"    Alternatives to standard procedural sedation such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    and general anesthesia are particularly useful in patients who cannot be adequately sedated using standard regimens or who are perceived to be at high risk for agitation unless a deeper level of sedation is achieved. In certain settings, assistance from an anesthesiologist may be required (",
"    <a class=\"graphic graphic_table graphicRef78317 \" href=\"mobipreview.htm?12/43/12987\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H144782966\">",
"    <span class=\"h1\">",
"     ADJUNCTS TO MODERATE PROCEDURAL SEDATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adjuncts to moderate procedural sedation are used to decrease the doses of benzodiazepines and opiates required for gastrointestinal endoscopy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    improve sedation in patients who are difficult to sedate.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     Diphenhydramine",
"    </a>",
"    is a more commonly used adjunct, whereas",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"     droperidol",
"    </a>",
"    is being used with decreasing frequency due to its potential to cause prolongation of the QTc interval and torsade de points. The use of pharyngeal anesthesia in patients undergoing endoscopic procedures of the upper gastrointestinal tract is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/22/24936?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of procedural sedation for gastrointestinal endoscopy\", section on 'Pharyngeal anesthesia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H144783248\">",
"    <span class=\"h2\">",
"     Diphenhydramine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     Diphenhydramine",
"    </a>",
"    is a histamine 1 antagonist that has central nervous system depressant effects and has been used as an adjunct to sedation with benzodiazepines and opiates. Diphenhydramine is often used for patients who may not adequately respond to standard procedural sedation, such as those who use benzodiazepines or opiates chronically as outpatients. Typically, 25 to 50 mg of diphenhydramine is given intravenously prior to or concurrent with starting procedural sedation.",
"   </p>",
"   <p>",
"    Side effects associated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    include dizziness, blurred vision, dry mouth, epigastric discomfort, thickening of bronchial secretions, and urinary retention.",
"   </p>",
"   <p>",
"    Data are limited on the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    for gastrointestinal endoscopy. In a randomized trial, 270 patients undergoing colonoscopy were assigned to receive either 50 mg of intravenous diphenhydramine or placebo given three minutes prior to starting procedural sedation with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/7\">",
"     7",
"    </a>",
"    ]. Patients in the diphenhydramine group had a 10 percent reduction in meperidine use and a 14 percent reduction in midazolam use. In addition, more favorable patient scores for overall sedation and pain were seen in the diphenhydramine group. There were no differences between the groups with regard to procedure time, recovery time, or total time from study drug administration to discharge from the endoscopy unit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H144783255\">",
"    <span class=\"h2\">",
"     Droperidol",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"     Droperidol",
"    </a>",
"    is a butyrophenone neuroleptic tranquilizer that may be used in combination with opioids and benzodiazepines for procedural sedation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/8-15\">",
"     8-15",
"    </a>",
"    ]. However, droperidol has been associated with QTc prolongation and the development of torsades de pointes in at least 20 cases reported to the US Food and Drug Administration, prompting it to issue a",
"    <a class=\"external\" href=\"file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm173778.htm\">",
"     black box warning",
"    </a>",
"    in 2001 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/16\">",
"     16",
"    </a>",
"    ]. As a result, its use has been greatly reduced in the United States. The drug was removed from the European market in March 2001.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"     Droperidol",
"    </a>",
"    produces anti-emetic and anti-anxiety effects. It also has mild sedative and alpha-adrenergic inhibitory action. The most common side effects are mild to moderate hypotension and tachycardia. Prolonged post-procedure drowsiness has been reported, and extrapyramidal side effects such as dystonia can occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H144784449\">",
"    <span class=\"h3\">",
"     Role for droperidol",
"    </span>",
"    &nbsp;&mdash;&nbsp;The black box warning issued regarding",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"     droperidol",
"    </a>",
"    has greatly reduced its role in procedural sedation. As the warning suggests, its use should be limited to patients who cannot be adequately sedated with standard medications. In addition, we recommend that its use be limited to situations in which an anesthesiologist is not available to administer",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    or general anesthesia for a procedure that requires deeper levels of sedation (due to either procedure- or patient-related factors). However, provided that all precautions are taken (",
"    <a class=\"graphic graphic_table graphicRef54264 \" href=\"mobipreview.htm?17/25/17819\">",
"     table 2",
"    </a>",
"    ), studies suggest that adding droperidol to an",
"    <span class=\"nowrap\">",
"     opioid/benzodiazepine",
"    </span>",
"    regimen for procedural sedation in patients undergoing therapeutic endoscopic procedures can lead to fewer sedation-associated interruptions and reduced",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    requirements. (See",
"    <a class=\"local\" href=\"#H144783277\">",
"     'Efficacy of droperidol'",
"    </a>",
"    below.).",
"   </p>",
"   <p>",
"    Guidelines on the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"     droperidol",
"    </a>",
"    for gastrointestinal endoscopy have been outlined in a consensus statement issued by the American Society for Gastrointestinal Endoscopy (",
"    <a class=\"graphic graphic_table graphicRef54264 \" href=\"mobipreview.htm?17/25/17819\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H144784321\">",
"    <span class=\"h3\">",
"     Administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our experience,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"     droperidol",
"    </a>",
"    is most useful when given before the procedure (instead of during the procedure), such as when a patient is already experiencing a paradoxical agitation to a benzodiazepine. Generally we prefer",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    -based regimens to the use of droperidol, but administering propofol may not be an option if an anesthesiologist is not available. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Propofol'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Prior to administering",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"     droperidol",
"    </a>",
"    , a 12-lead electrocardiogram should be obtained [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/17\">",
"     17",
"    </a>",
"    ]. If the QTc is prolonged (&gt;440 milliseconds for men or &gt;450 milliseconds for women), droperidol is contraindicated. In addition, droperidol should be used with caution in patients at risk for development of prolonged QTc syndrome (",
"    <a class=\"graphic graphic_table graphicRef54264 \" href=\"mobipreview.htm?17/25/17819\">",
"     table 2",
"    </a>",
"    ). Patients should remain on cardiac monitoring during the procedure and for two to three hours following the procedure.",
"   </p>",
"   <p>",
"    We administer 2.5 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"     droperidol",
"    </a>",
"    (2.5",
"    <span class=\"nowrap\">",
"     mg/mL)",
"    </span>",
"    along with a benzodiazepine (to avoid dystonia or dysphoria, which may occur if droperidol is given alone) and an opiate. After five minutes, additional 1.25 aliquots may be given if needed. The recommended maximum dose is 5 mg. We do not administer additional boluses of droperidol for agitation once we are well into the procedure because by the time such additional doses take maximal effect, the procedure may be nearly completed and the recovery time may be prolonged.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H144783277\">",
"    <span class=\"h3\">",
"     Efficacy of droperidol",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"     Droperidol",
"    </a>",
"    has been studied as an adjunct to procedural sedation with standard medications for various endoscopic procedures, including colonoscopy, upper endoscopy, endoscopic retrograde cholangiopancreatography (ERCP), and endoscopic ultrasound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/8-14,18-28\">",
"     8-14,18-28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Representative studies have shown the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the largest published retrospective series with 764 patients undergoing 1102 endoscopic procedures (including 295 ERCPs), the administration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"       droperidol",
"      </a>",
"      (2.5 to 3.75 mg) along with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"       meperidine",
"      </a>",
"      and a benzodiazepine was safe and effective [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/8\">",
"       8",
"      </a>",
"      ]. The drug was most commonly used in patients actively abusing alcohol (45 percent). Only 11 procedures could not be completed due to agitation, while 11 others were completed with difficulty. The main complication was transient hypotension, which occurred during 14 procedures (1 percent). This was reversible with intravenous fluid",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/24/35207?source=see_link\">",
"       naloxone",
"      </a>",
"      in all cases. There were no reported cases of arrhythmias, prolonged QTc intervals, or extrapyramidal side effects.",
"     </li>",
"     <li>",
"      A randomized trial included 140 patients undergoing elective upper endoscopy who were assigned to procedural sedation with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"       meperidine",
"      </a>",
"      with or without",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"       droperidol",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/14\">",
"       14",
"      </a>",
"      ]. A 10 percent reduction in procedure time, a significant reduction in meperidine and midazolam requirements, and a significant decrease in the typical procedure-associated increase in heart rate were observed in patients assigned to droperidol. There was no hypotension attributed to droperidol, and no significant side effects were observed. However, four patients in the droperidol group were given",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/24/35207?source=see_link\">",
"       naloxone",
"      </a>",
"      for persistent drowsiness 30 minutes into recovery.",
"     </li>",
"     <li>",
"      Another randomized trial focused on patients who were at high risk for difficult sedation and were treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"       droperidol",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"      or with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      and fentanyl [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/9\">",
"       9",
"      </a>",
"      ]. High-risk patients included those with prior benzodiazepine sedation failures leading to incomplete procedures (12 percent), patients with severe anxiety (64 percent), and chronic benzodiazepine or tranquilizer users (34 percent). Although this study was blinded only to the staff endoscopist rating the procedure, the droperidol group had significantly lower incidences of inadequate sedation and less post-procedure somnolence and confusion than the diazepam group [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H144782877\">",
"    <span class=\"h1\">",
"     ALTERNATIVES TO MODERATE PROCEDURAL SEDATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alternatives to moderate sedation include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    and general anesthesia. These approaches are used for patients who are difficult to sedate or who are undergoing procedures that require deep sedation. In some centers, propofol is also being used for routine endoscopy to improve patient tolerance and to decrease recovery times. However, in many areas, propofol must be administered by an anesthesiologist, limiting its use for routine endoscopic procedures.",
"   </p>",
"   <p>",
"    Other agents that have been studied for sedation for procedures other than endoscopy include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    , barbiturates, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    . The use of these agents is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34618?source=see_link\">",
"     \"Procedural sedation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Propofol",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     Propofol",
"    </a>",
"    is a substituted isopropylphenol medication, which promotes GABA activity in the brain. While it may be used as a single agent, it is typically administered along with small bolus doses of a short-acting opioid (such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    ) and a benzodiazepine, a combination termed \"balanced propofol sedation\". (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Balanced propofol sedation'",
"    </a>",
"    below.) For longer procedures, such as endoscopic retrograde cholangiopancreatography (ERCP), propofol is typically given as an intravenous drip.",
"   </p>",
"   <p>",
"    Benefits of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    include a rapid onset of action (two to four minutes) and rapid reversibility of effect once the drip is shut off. It has some antiemetic effect and has a weaker amnestic effect than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    , but no analgesic activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/29\">",
"     29",
"    </a>",
"    ]. Propofol did not influence the sphincter of Oddi pressure reading in a study of 10 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/30\">",
"     30",
"    </a>",
"    ] and can be used in patients who are undergoing sphincter of Oddi manometry.",
"   </p>",
"   <p>",
"    The major drawback of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    is its effect as a respiratory depressant. Reversal is only possible by stopping the medication and maintaining ventilation until the medication effect elapses.",
"   </p>",
"   <p>",
"    A survey of gastroenterologists in the United States published in 2006 found that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    was being used for sedation in approximately 25 percent of endoscopies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/31\">",
"     31",
"    </a>",
"    ]. However, since the time of this publication, the frequency of use has probably grown considerably.",
"   </p>",
"   <p>",
"    We generally use",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    for patients who cannot be adequately sedated with standard medications. (See",
"    <a class=\"local\" href=\"#H144783255\">",
"     'Droperidol'",
"    </a>",
"    above.) Given the black box warning for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"     droperidol",
"    </a>",
"    , propofol-based sedation is favored in this situation. We are more likely to choose this approach for elective cases in which we have time to arrange for assistance from an anesthesiologist. We also favor propofol for elderly patients and those with a history of seizure disorder in whom droperidol should be avoided.",
"   </p>",
"   <p>",
"    Recommendations for the appropriate personnel and equipment needed for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    sedation have been issued in a consensus statements from the American Society for Gastrointestinal Endoscopy (",
"    <a class=\"graphic graphic_table graphicRef62941 \" href=\"mobipreview.htm?12/60/13259\">",
"     table 3",
"    </a>",
"    ) and in",
"    <a class=\"external\" href=\"file://www.esge.com/assets/downloads/pdfs/guidelines/2010_non_anesthesiologist_admin_propofol_gi_endo.pdf\">",
"     recommendations",
"    </a>",
"    from the European Society for Gastrointestinal Endoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/17,32,33\">",
"     17,32,33",
"    </a>",
"    ]. While these recommendations do not include the routine use of capnography for monitoring patients receiving propofol, studies suggest that the use of capnography results in less hypoxia and leads to earlier detection of hypoxia when it occurs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/22/24936?source=see_link&amp;anchor=H4#H4\">",
"     \"Overview of procedural sedation for gastrointestinal endoscopy\", section on 'Monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Efficacy of propofol",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have demonstrated the utility of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    in sedating patients for endoscopic procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/35-44\">",
"     35-44",
"    </a>",
"    ]. A meta-analysis of 20 randomized controlled trials comparing propofol with other sedation regimens for colonoscopy found that propofol sedation was associated with faster recovery and discharge times and increased patient satisfaction without increased side-effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/45\">",
"     45",
"    </a>",
"    ]. However, the authors called for more studies to compare propofol administration by anesthesiologists with administration by non-anesthesiologists. The following are illustrative of the individual trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One of the largest randomized trials included 198 patients undergoing ERCP who were assigned to receive",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      for sedation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/36\">",
"       36",
"      </a>",
"      ]. Six of the 98 patients in the midazolam group also received a 30 mg dose of the analgesic",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/48/29446?source=see_link\">",
"       pentazocine",
"      </a>",
"      .",
"      <br/>",
"      <br/>",
"      The patients receiving propofol had significantly better observer ratings of patient cooperation and significantly shorter onset of effective sedation, procedure, and recovery room times. One patient in the propofol group developed apnea, which required eight minutes of bag-mask ventilation. There was no difference in patient post-procedure ratings of sedation quality. A limitation of this study was the lack of opioids in the non-propofol regimen.",
"     </li>",
"     <li>",
"      A second trial with a similar design showed that",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      significantly increased the likelihood of a complete examination with adequate sedation (98 versus 80 percent) compared with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      sedation. Two patients in the propofol group developed dyspnea due to airway obstruction by their tongue while being turned from supine to prone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A third controlled trial of 75 patients undergoing ERCP and endoscopic ultrasound found that those receiving",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      had a significantly faster induction time, shorter recovery time, and higher recovery of both baseline activity and dietary intake at 24 hours [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/39\">",
"       39",
"      </a>",
"      ]. The authors estimated that these benefits cost $403 extra per case to have a second clinician present but would be cost-neutral if propofol could be administered by a registered nurse.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other studies have demonstrated that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    is more effective than",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    -based sedation for colonoscopy, can be administered safely by gastroenterologists and nurses, and can be administered to high-risk elderly patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/46-51\">",
"     46-51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies in patients undergoing colonoscopy mostly evaluated patients who were not at any particular increased risk for having difficulty with sedation using standard medications. It can be argued that the increased risk of respiratory depression and the shorter nature of most colonoscopic examinations make",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    less appropriate than standard procedural sedation for colonoscopy unless a patient fails a standard regimen. However, with improved patient satisfaction and acceptance of colonoscopy and increased efficiency in the unit, the use of propofol could improve the overall rate of screening. Added costs per procedure must be weighed against the potential savings resulting from increased screening of the at-risk population. At present, it remains an unresolved issue whether the use of propofol for routine colonoscopy sedation is worth the added per case cost and risks associated with its administration, either by an anesthesiologist or by another trained health care provider. (See",
"    <a class=\"local\" href=\"#H144784683\">",
"     'Administration by non-anesthesiologists'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Balanced propofol sedation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Balanced",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    sedation uses combinations of low-dose benzodiazepines and opioids along with lower doses of propofol. The goal is to achieve moderate levels of sedation rather than the deep levels of sedation typically produced using propofol monotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/52\">",
"     52",
"    </a>",
"    ]. As such, it can be used for routine endoscopic procedures that do not typically require deep sedation.",
"   </p>",
"   <p>",
"    In a randomized trial with 222 patients, balanced",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    sedation was compared with conventional sedation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/53\">",
"     53",
"    </a>",
"    ]. Patients in the balanced propofol sedation arm received a combination of propofol,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    , whereas patients in the conventional sedation arm received midazolam and meperidine. There was no difference between the groups with regard to adverse outcomes or patient satisfaction. However, clinicians and nurses reported better satisfaction with balanced propofol sedation.",
"   </p>",
"   <p>",
"    In a second randomized trial, 110 patients undergoing outpatient upper endoscopy were assigned to receive either balanced",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    sedation or conventional sedation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/54\">",
"     54",
"    </a>",
"    ]. Patients who received balanced propofol sedation reported higher median procedural satisfaction (99 versus 85 on a 100-point scale). Balanced propofol sedation was also associated with a shorter median recovery time (11 versus 23 minutes).",
"   </p>",
"   <p>",
"    It is important to realize that for complicated, longer procedures and in difficult to sedate patients, anesthesiologists employ a wide variety of strategies, often employing",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    in IV drip form rather than bolus administration and often in conjunction with other drugs. It is hoped that innovations such as balanced propofol sedation and innovative automated devices to control propofol administration based on feedback data derived from the monitoring of patient vital signs and responsiveness during procedures will enhance the safety of propofol use. (See",
"    <a class=\"local\" href=\"#H28218864\">",
"     'Computer-assisted personalized sedation'",
"    </a>",
"    below.) Such developments will help overcome obstacles currently limiting its use by trained personnel other than anesthesiologists, such as current FDA labeling of the drug.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Patient-controlled analgesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     Propofol",
"    </a>",
"    has also been administered in the setting of patient-controlled analgesia (PCA). However, while patients do control when additional amounts of drug are administered, the amount propofol administered is strictly limited, and patients still must be continuously monitored by personnel trained in airway management in the event of oversedation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two controlled trials of PCA for colonoscopy (using different protocols) concluded that regimens involving PCA with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      were associated with faster recovery compared with standard approaches and good patient-satisfaction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/55,56\">",
"       55,56",
"      </a>",
"      ]. The relative costs were not reported.",
"     </li>",
"     <li>",
"      A small study investigated the feasibility of using",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      PCA for ERCP; while 16 out of 20 examinations could be completed using this technique, the infusion took up to 28 minutes before adequate levels of sedation could be reached to start the procedure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A randomized trial also looked at using patient-administered",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/50/5927?source=see_link\">",
"       remifentanil",
"      </a>",
"      for ERCP [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/58\">",
"       58",
"      </a>",
"      ]. Eighty patients were assigned to receive either patient-controlled sedation (PSC) with propofol and remifentanil or anesthesiologist-managed propofol sedation. Patients in the PCS arm received less propofol and were not as deeply sedated as patients in the anesthesiologist managed arm. There were no differences between the groups with regard to endoscopist or patient satisfaction. However, two patients in the PCS required additional doses of propofol administered by an anesthesiologist. There was one case of respiratory depression in the PCS arm.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28218864\">",
"    <span class=\"h3\">",
"     Computer-assisted personalized sedation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computer-assisted personalized sedation (CAPS) has been developed to permit safe administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    by healthcare providers who are not trained in general anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/59\">",
"     59",
"    </a>",
"    ]. The SEDASYS CAPS system (Ethicon Endo-Surgery Inc, Cincinnati, OH) is in use in Canada for patients undergoing colonoscopy and in Australia for patients undergoing colonoscopy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    upper endoscopy. The system has been granted the Conformit&eacute; Europ&eacute;ene (CE) mark of approval in the European Union, but it is not approved by the FDA.",
"   </p>",
"   <p>",
"    CAPS can be used for colonoscopy or upper endoscopy in patients who are relatively healthy (ASA class I or II) (",
"    <a class=\"graphic graphic_table graphicRef78084 \" href=\"mobipreview.htm?9/5/9307\">",
"     table 4",
"    </a>",
"    ). The initial",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    rate is set by the healthcare provider, up to a maximum of 75",
"    <span class=\"nowrap\">",
"     mcg/kg/min.",
"    </span>",
"    During the procedure, the provider can increase or decrease the rate of propofol administration, give bolus doses if needed, and stop the infusion. The system continuously monitors physiologic patient data such as oxygen saturation, capnometry, respiratory rate, heart rate, blood pressure, electrocardiography, and patient responsiveness. Patient responsiveness is assessed by calculating how long it takes for the patient to squeeze a handset after being instructed to do so by the bedside monitoring unit. The unit delivers both an auditory command and vibration of the handset. Based upon the patient's physiologic parameters and response time, the system adjusts the rate of propofol administration. If the patient's physiologic parameters suggest oversedation, the system will decrease or stop the infusion rate (depending upon the degree of sedation) and increase oxygen delivery to the patient.",
"   </p>",
"   <p>",
"    Data suggest that the use of CAPS for sedation is safe and that it is associated with decreased recovery times [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. It is also associated with increased patient and endoscopist satisfaction compared with standard sedation with opioids and benzodiazepines.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H144784683\">",
"    <span class=\"h3\">",
"     Administration by non-anesthesiologists",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major drawback of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    is its effect as a respiratory depressant. Reversal is only possible by stopping the medication and maintaining ventilation until the medication effect elapses. Propofol also inhibits an individual's protective airway reflex; as a result, whenever propofol is administered, the person responsible for managing the sedation must be fully trained and capable of protecting the airway. For these reasons, the use of propofol has been limited to anesthesiologists in most centers in the United States. On the other hand, there is growing experience and literature establishing outstanding safety data for the administration of propofol-based sedation by non-anesthesiologist nurses and clinicians highly trained in airway management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/52,62-65\">",
"     52,62-65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a study looking at 646,080 endoscopic cases performed with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    administered by non-anesthesiologist nurses and clinicians, there were only four deaths, with bag-mask ventilation being required in 0.1 percent of upper endoscopies and 0.01 percent of colonoscopies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/66\">",
"     66",
"    </a>",
"    ]. However, much of this experience has been with use during routine endoscopy in low-risk patients. Among individuals at higher risk for difficulty with sedation, those with risk factors for sedation complications (eg, advanced age or underlying comorbid illnesses), and those having prolonged procedures requiring deeper levels of sedation, the practice of non-anesthesiologist administration of propofol is less well supported. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/41/28310?source=see_link&amp;anchor=H3#H3\">",
"     \"Complications of procedural sedation for gastrointestinal endoscopy\", section on 'Sedatives and analgesics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a 2009 position statement, the use of non-anesthesiologist-administered",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    for gastrointestinal endoscopy in healthy, low-risk patients was endorsed by the American Association for the Study of Liver Diseases, the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/67\">",
"     67",
"    </a>",
"    ]. The position statement stresses that anyone administering propofol needs specialized training in its use, including instruction in airway management.",
"   </p>",
"   <p>",
"    Despite this recommendation, there remain many local barriers to administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    by non-anesthesiologists, such as state nursing boards, state licensing regulation, the",
"    <a class=\"external\" href=\"file://www.cms.gov/SurveyCertificationGenInfo/downloads/SCLetter10_09.pdf\">",
"     Centers for Medicaid and Medicare Services",
"    </a>",
"    requirement that propofol be administered by a practitioner qualified to administer anesthesia, and the FDA-approved drug labeling for propofol.",
"   </p>",
"   <p>",
"    While the need for an anesthesiologist increases the cost of endoscopy and can be difficult logistically, these costs may be justified in selected patients since",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    permits deep sedation and rapid recovery of otherwise difficult to sedate patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Laryngeal mask airway",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laryngeal mask airway (LMA) is a device approved by the FDA that is placed perorally to make a seal over the vocal cords. It is used as an alternative to endotracheal intubation during general anesthesia. It has the advantage of not traversing the vocal cords, thus reducing airway stimulation so muscle relaxants are not required. It remains controversial whether non-anesthesiologists can be properly trained to use an LMA to allow for the administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    for procedures requiring prolonged deep sedation. This remains the biggest obstacle to the more widespread use of this device for ERCP and other therapeutic endoscopic procedures.",
"   </p>",
"   <p>",
"    Data suggest that an LMA can be used to facilitate airway protection during therapeutic ERCP with deep sedation without interfering with the examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/68\">",
"     68",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A retrospective study included 32 patients who underwent 41 ERCPs during a 30-month period. Twelve of the patients received endotracheal intubation, and 20 had an LMA. Patients were excluded from receiving an LMA if an anesthesiologist determined they were at high-risk for aspiration (ascites, obesity, or abdominal distension) or were likely to be difficult to intubate.",
"      <br/>",
"      <br/>",
"      All patients received topical pharyngeal anesthesia. After administration of sedation (combinations of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"       meperidine",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      ), the LMA (diameter 10 mm) was placed by the anesthesiologist with the patient in the supine position. A bite block was placed adjacent to the LMA, the patient was turned to the prone position, and the staff gastroenterologist passed the duodenoscope. In all cases, the endoscope was pushed around the LMA without dislodging the distensible rubber seal (repositioning of the LMA was required in one patient). Friction between the endoscope and the LMA during the procedures was either completely absent or trivial.",
"      <br/>",
"      <br/>",
"      Supplemental oxygen could be delivered via the LMA, and any hypoventilation due to deep sedation could be immediately managed by attaching an Ambu bag to the LMA to ventilate the patient in a similar fashion to an endotracheal-intubated patient. In one patient, the seal loosened during the procedure, leading to transient hypoxemia. This was treated by quickly removing the endoscope, repositioning the LMA, and then proceeding with the rest of the procedure. There were no clinically significant complications and no instances of aspiration. Time until extubation was significantly shorter in patients in the LMA group than in the endotracheal intubation group (7.2 versus 12 minutes). Patients reported no post-procedure complaints of inadequate sedation or oropharyngeal discomfort.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further study is warranted to determine whether the LMA will facilitate",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    -based sedation by non-anesthesiologists and whether the LMA confers safety benefits over standard nasal cannula oxygenation for patients receiving deep levels of sedation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H160962131\">",
"    <span class=\"h3\">",
"     Bispectral (BIS) monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bispectral monitoring uses continuous electroencephalogram recordings to generate an objective assessment of the degree of sedation. A value on a linear scale from 100 (fully awake) to 0 (no brain-wave activity) is continually updated during a procedure to reflect recent brain wave activity. BIS values correlated well with the Observer's Assessment of",
"    <span class=\"nowrap\">",
"     Alertness/Sedation",
"    </span>",
"    <span class=\"nowrap\">",
"     (OAA/S)",
"    </span>",
"    scale in a study of 50 patients undergoing endoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/69\">",
"     69",
"    </a>",
"    ]. This technology has the potential to prevent oversedation and may have a role in making",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    safer to administer in the future [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     General anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;General anesthesia is used most commonly in children and for individuals who are unable to tolerate procedural sedation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19817?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of anesthesia and anesthetic choices\", section on 'General anesthesia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies have shown that general anesthesia is used in a small minority of procedures:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective study of 2711 upper and lower endoscopies in 2026 children, adolescents, and young adults, 3.5 percent of procedures were performed under general anesthesia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/71\">",
"       71",
"      </a>",
"      ]. The indications for general anesthesia in this series were failed previous attempts at examination using procedural sedation, mental retardation, simultaneous procedures with another procedure requiring anesthesia, and an expected long, difficult examination. Scheduling difficulties, cost considerations, concern about airway trauma, and anesthetic complications all contribute to the reluctance to use general anesthesia, even in children.",
"     </li>",
"     <li>",
"      During a two-year period at four teaching hospitals, 65 of 1200 patients undergoing ERCP (5.4 percent) received general anesthesia and endotracheal intubation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/72\">",
"       72",
"      </a>",
"      ]. Seven of these were children. Fifty-three of the remaining 56 evaluated had failed one or more prior attempted ERCP using procedural sedation. Forty-eight percent of those with failed prior attempts were current abusers of alcohol",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      drugs. Significantly more substance abusers failed ERCP under procedural sedation compared with non-substance abusers (30 versus 2 percent). Other reasons for general anesthesia included non-substance abusers with prior failed procedure attempts due to agitation, adverse reactions to prior procedural sedation, septic shock, and myasthenia gravis.",
"      <br/>",
"      <br/>",
"      This study underscores the fact that adults who required general anesthesia for ERCP had characteristics that were generally considered to be risk factors for difficult sedation. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Patients who are likely to be difficult to sedate'",
"      </a>",
"      above.) This supports the conclusion that these patient-related factors are important considerations in choosing the sedation regimen. However, no prospective or good retrospective analyses have been published to confirm which patient characteristics are significant predictors of inadequate sedation with standard medications alone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In adults, general anesthesia is usually the sedation method of last resort with a few major exceptions. In patients who are obtunded, those with high aspiration risk, and those with active hematemesis, endotracheal intubation provides the best available airway protection. Assessment of the airway and the patient's risk of aspiration are essential prior to the administration of sedation. An elective intubation by an anesthesiologist may be preferable to a potential emergency intubation in an individual deemed to be at risk for a difficult intubation, undergoing a procedure that requires a deep level of sedation. Factors influencing potential difficulty with intubation include relative tongue size, neck flexibility, mouth opening, jaw size, and the presence of teeth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/2/43049/abstract/29\">",
"     29",
"    </a>",
"    ]. Careful assessment of the patient's airway and risk factors for aspiration are best performed well in advance of the procedure to permit an opportunity to select the appropriate setting to perform the endoscopy and to arrange for anesthesiology assistance if needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H144784253\">",
"    <span class=\"h2\">",
"     Sedation-free endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The performance of endoscopic procedures in unsedated patients is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/44/42694?source=see_link\">",
"     \"Sedation-free gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28218957\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of gastrointestinal endoscopy has greatly expanded the diagnostic and therapeutic capabilities of gastroenterologists. Adequate patient tolerance is essential for successful completion of a safe examination and compliance with subsequent follow-up. As a result, endoscopists have developed skills in administering a variety of sedative and analgesic agents to facilitate procedures and enhance patient comfort.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endoscopists occasionally encounter individuals who are difficult or impossible to adequately sedate for endoscopy using standard agents. In addition, certain therapeutic endoscopic procedures require deeper levels of sedation. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Characteristics of patients who are difficult to sedate using standard regimens have not been well established. However, several characteristics are generally considered to be risk factors for difficult sedation including (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Patients who are likely to be difficult to sedate'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A history of prior difficulty with procedural sedation",
"     </li>",
"     <li>",
"      Prescribed or illicit benzodiazepine or opioid use",
"     </li>",
"     <li>",
"      Heavy alcohol use",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adjuncts to moderate procedural sedation are used to decrease the doses of benzodiazepines and opiates required for gastrointestinal endoscopy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      improve sedation in patients who are difficult to sedate.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"       Diphenhydramine",
"      </a>",
"      is a commonly used adjunct, whereas",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"       droperidol",
"      </a>",
"      is being used with decreasing frequency due to its potential to cause prolongation of the QTc interval and torsade de pointes. (See",
"      <a class=\"local\" href=\"#H144782966\">",
"       'Adjuncts to moderate procedural sedation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Alternatives to moderate procedural sedation include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      and general anesthesia. These approaches are used for patients who are difficult to sedate or who are undergoing procedures that require deep sedation. In some centers, propofol is also being used for routine endoscopy to improve patient tolerance and to decrease recovery times. However, in many areas, propofol must be administered by an anesthesiologist, limiting its use for routine endoscopic procedures. (See",
"      <a class=\"local\" href=\"#H144782877\">",
"       'Alternatives to moderate procedural sedation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/1\">",
"      Cook PJ, Flanagan R, James IM. Diazepam tolerance: effect of age, regular sedation, and alcohol. Br Med J (Clin Res Ed) 1984; 289:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/2\">",
"      Pe&ntilde;a LR, Mardini HE, Nickl NJ. Development of an instrument to assess and predict satisfaction and poor tolerance among patients undergoing endoscopic procedures. Dig Dis Sci 2005; 50:1860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/3\">",
"      Schutz SM, Lee JG, Schmitt CM, et al. Clues to patient dissatisfaction with conscious sedation for colonoscopy. Am J Gastroenterol 1994; 89:1476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/4\">",
"      Mahajan RJ, Johnson JC, Marshall JB. Predictors of patient cooperation during gastrointestinal endoscopy. J Clin Gastroenterol 1997; 24:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/5\">",
"      Bal BS, Crowell MD, Kohli DR, et al. What factors are associated with the difficult-to-sedate endoscopy patient? Dig Dis Sci 2012; 57:2527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/6\">",
"      Lee SY, Son HJ, Lee JM, et al. Identification of factors that influence conscious sedation in gastrointestinal endoscopy. J Korean Med Sci 2004; 19:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/7\">",
"      Tu RH, Grewall P, Leung JW, et al. Diphenhydramine as an adjunct to sedation for colonoscopy: a double-blind randomized, placebo-controlled study. Gastrointest Endosc 2006; 63:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/8\">",
"      Wilcox CM, Forsmark CE, Cello JP. Utility of droperidol for conscious sedation in gastrointestinal endoscopic procedures. Gastrointest Endosc 1990; 36:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/9\">",
"      Rozen P, Ratan J, Gilat T. Fentanyl-droperidol neuroleptanalgesia in gastrointestinal endoscopy. Gastrointest Endosc 1977; 23:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/10\">",
"      Le Brun HI. Neuroleptanalgesia in upper alimentary endoscopy. Gut 1976; 17:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/11\">",
"      Rubin J, Bryer JV, Brock-Utne JG, Moshal MG. The use of neurolept analgesia for gastro-intestinal endoscopy. S Afr Med J 1977; 52:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/12\">",
"      Moshal MG, Rubin J, Greenberg MJ, et al. Variable premedication for upper gastrointestinal endoscopy. Am J Gastroenterol 1979; 71:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/13\">",
"      Reed WD, Hopkins BE, Joske RA, Laurence BH. A comparative study of conventional premedication (pethidine, promethazine, and atropine) and neuroleptanalgesia (droperidol and phenoperidine) for peroral endoscopy. Gut 1971; 12:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/14\">",
"      Barthel JS, Marshall JB, King PD, et al. The effect of droperidol on objective markers of patient cooperation and vital signs during esophagogastroduodenoscopy: a randomized, double-blind, placebo-controlled, prospective investigation. Gastrointest Endosc 1995; 42:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/15\">",
"      Claussen D. Droperidol (Inapsine). Gastroenterol Nurs 1992; 15:81.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm173778.htm (Accessed on June 24, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/17\">",
"      Faigel DO, Baron TH, Goldstein JL, et al. Guidelines for the use of deep sedation and anesthesia for GI endoscopy. Gastrointest Endosc 2002; 56:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/18\">",
"      al-Atrakchi HA. Upper gastrointestinal endoscopy without sedation: a prospective study of 2000 examinations. Gastrointest Endosc 1989; 35:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/19\">",
"      De Gregorio BT, Poorman JC, Katon RM. Peroral ultrathin endoscopy in adult patients. Gastrointest Endosc 1997; 45:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/20\">",
"      Tan CC, Freeman JG. Throat spray for upper gastrointestinal endoscopy is quite acceptable to patients. Endoscopy 1996; 28:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/21\">",
"      Solomon SA, Kajla VK, Banerjee AK. Can the elderly tolerate endoscopy without sedation? J R Coll Physicians Lond 1994; 28:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/22\">",
"      Dhir V, Swaroop VS, Vazifdar KF, Wagle SD. Topical pharyngeal anesthesia without intravenous sedation during upper gastrointestinal endoscopy. Indian J Gastroenterol 1997; 16:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/23\">",
"      Schutz SM, Lee JG, Schmitt CM, Baillie J. Patient satisfaction with conscious sedation for endoscopy. Gastrointest Endosc 1994; 40:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/24\">",
"      Cohen J, Haber GB, Dorais JA, et al. A randomized, double-blind study of the use of droperidol for conscious sedation during therapeutic endoscopy in difficult to sedate patients. Gastrointest Endosc 2000; 51:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/25\">",
"      Wille RT, Barnett JL, Chey WD, et al. Routine droperidol pre-medication improves sedation for ERCP. Gastrointest Endosc 2000; 52:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/26\">",
"      Wilcox CM, Linder J. Prospective evaluation of droperidol on sphincter of Oddi motility. Gastrointest Endosc 2003; 58:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/27\">",
"      Fogel EL, Sherman S, Bucksot L, et al. Effects of droperidol on the pancreatic and biliary sphincters. Gastrointest Endosc 2003; 58:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/28\">",
"      Yimcharoen P, Fogel EL, Kovacs RJ, et al. Droperidol, when used for sedation during ERCP, may prolong the QT interval. Gastrointest Endosc 2006; 63:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/29\">",
"      Graber RG. Propofol in the endoscopy suite: an anesthesiologist's perspective. Gastrointest Endosc 1999; 49:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/30\">",
"      Goff JS. Effect of propofol on human sphincter of Oddi. Dig Dis Sci 1995; 40:2364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/31\">",
"      Cohen LB, Wecsler JS, Gaetano JN, et al. Endoscopic sedation in the United States: results from a nationwide survey. Am J Gastroenterol 2006; 101:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/32\">",
"      Dumonceau JM, Riphaus A, Aparicio JR, et al. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy 2010; 42:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/33\">",
"      Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy, Lichtenstein DR, Jagannath S, et al. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc 2008; 68:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/34\">",
"      Deitch K, Miner J, Chudnofsky CR, et al. Does end tidal CO2 monitoring during emergency department procedural sedation and analgesia with propofol decrease the incidence of hypoxic events? A randomized, controlled trial. Ann Emerg Med 2010; 55:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/35\">",
"      Carlsson U, Grattidge P. Sedation for upper gastrointestinal endoscopy: a comparative study of propofol and midazolam. Endoscopy 1995; 27:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/36\">",
"      Wehrmann T, Kokabpick S, Lembcke B, et al. Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointest Endosc 1999; 49:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/37\">",
"      Jung M, Hofmann C, Kiesslich R, Brackertz A. Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam. Endoscopy 2000; 32:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/38\">",
"      Kim LS, Cammarano WB, Querimit LA, et al. Randomized controlled trial of propofol for patient sedation during endoscopic retrograde cholangiopancreatography (ERCP) (abstract). Gastrointest Endosc 1998; 47:AB53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/39\">",
"      Vargo JJ, Zuccaro G Jr, Dumot JA, et al. Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial. Gastroenterology 2002; 123:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/40\">",
"      Ulmer BJ, Hansen JJ, Overley CA, et al. Propofol versus midazolam/fentanyl for outpatient colonoscopy: administration by nurses supervised by endoscopists. Clin Gastroenterol Hepatol 2003; 1:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/41\">",
"      Yusoff IF, Raymond G, Sahai AV. Endoscopist administered propofol for upper-GI EUS is safe and effective: a prospective study in 500 patients. Gastrointest Endosc 2004; 60:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/42\">",
"      Fanti L, Agostoni M, Casati A, et al. Target-controlled propofol infusion during monitored anesthesia in patients undergoing ERCP. Gastrointest Endosc 2004; 60:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/43\">",
"      Sipe BW, Scheidler M, Baluyut A, Wright B. A prospective safety study of a low-dose propofol sedation protocol for colonoscopy. Clin Gastroenterol Hepatol 2007; 5:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/44\">",
"      Horiuchi A, Nakayama Y, Hidaka N, et al. Low-dose propofol sedation for diagnostic esophagogastroduodenoscopy: results in 10,662 adults. Am J Gastroenterol 2009; 104:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/45\">",
"      Singh H, Poluha W, Cheung M, et al. Propofol for sedation during colonoscopy. Cochrane Database Syst Rev 2008; :CD006268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/46\">",
"      Gepts E, Claeys MA, Camu F, Smekens L. Infusion of propofol ('Diprivan') as sedative technique for colonoscopies. Postgrad Med J 1985; 61 Suppl 3:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/47\">",
"      Pohlmann S, Herden HN, Hagenm&uuml;ller F. [Propofol narcosis for endoscopy--more dangerous than midazolam?]. Bildgebung 1993; 60 Suppl 1:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/48\">",
"      Sipe BW, Rex DK, Latinovich D, et al. Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists. Gastrointest Endosc 2002; 55:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/49\">",
"      Heuss LT, Schnieper P, Drewe J, et al. Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases. Gastrointest Endosc 2003; 57:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/50\">",
"      Walker JA, McIntyre RD, Schleinitz PF, et al. Nurse-administered propofol sedation without anesthesia specialists in 9152 endoscopic cases in an ambulatory surgery center. Am J Gastroenterol 2003; 98:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/51\">",
"      Riphaus A, Stergiou N, Wehrmann T. Sedation with propofol for routine ERCP in high-risk octogenarians: a randomized, controlled study. Am J Gastroenterol 2005; 100:1957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/52\">",
"      Dikman AE, Sanyal S, Aisenberg J, et al. Gastroenterologist-Directed, Balanced Propofol Sedation for EGD and Colonoscopy: An Analysis of Safety in 15,286 Patients. Gastrointest Endosc 2008; 67:AB84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/53\">",
"      Lee CK, Lee SH, Chung IK, et al. Balanced propofol sedation for therapeutic GI endoscopic procedures: a prospective, randomized study. Gastrointest Endosc 2011; 73:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/54\">",
"      Levitzky BE, Lopez R, Dumot JA, Vargo JJ. Moderate sedation for elective upper endoscopy with balanced propofol versus fentanyl and midazolam alone: a randomized clinical trial. Endoscopy 2012; 44:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/55\">",
"      K&uuml;lling D, Fantin AC, Biro P, et al. Safer colonoscopy with patient-controlled analgesia and sedation with propofol and alfentanil. Gastrointest Endosc 2001; 54:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/56\">",
"      Ng JM, Kong CF, Nyam D. Patient-controlled sedation with propofol for colonoscopy. Gastrointest Endosc 2001; 54:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/57\">",
"      Gillham MJ, Hutchinson RC, Carter R, Kenny GN. Patient-maintained sedation for ERCP with a target-controlled infusion of propofol: a pilot study. Gastrointest Endosc 2001; 54:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/58\">",
"      Mazanikov M, Udd M, Kyl&auml;np&auml;&auml; L, et al. Patient-controlled sedation with propofol and remifentanil for ERCP: a randomized, controlled study. Gastrointest Endosc 2011; 73:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/59\">",
"      ASGE Technology Committee, Banerjee S, Desilets D, et al. Computer-assisted personalized sedation. Gastrointest Endosc 2011; 73:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/60\">",
"      Pambianco DJ, Whitten CJ, Moerman A, et al. An assessment of computer-assisted personalized sedation: a sedation delivery system to administer propofol for gastrointestinal endoscopy. Gastrointest Endosc 2008; 68:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/61\">",
"      Pambianco DJ, Vargo JJ, Pruitt RE, et al. Computer-assisted personalized sedation for upper endoscopy and colonoscopy: a comparative, multicenter randomized study. Gastrointest Endosc 2011; 73:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/62\">",
"      Yimcharoen P, Fogel EL, McHenry L, et al. Use of Droperidol at ERCP and QTc Prolongation: Do We Need to Follow the Black Box Warning?. Gastrointest Endosc 2005; 61:AB125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/63\">",
"      Rex DK, Deenadayalu V, Eid E. Gastroenterologist-directed propofol: an update. Gastrointest Endosc Clin N Am 2008; 18:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/64\">",
"      K&uuml;lling D, Orlandi M, Inauen W. Propofol sedation during endoscopic procedures: how much staff and monitoring are necessary? Gastrointest Endosc 2007; 66:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/65\">",
"      Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology 2007; 133:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/66\">",
"      Rex DK, Deenadayalu VP, Eid E, et al. Endoscopist-directed administration of propofol: a worldwide safety experience. Gastroenterology 2009; 137:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/67\">",
"      Vargo JJ, Cohen LB, Rex DK, et al. Position statement: Nonanesthesiologist administration of propofol for GI endoscopy. Gastroenterology 2009; 137:2161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/68\">",
"      Osborn IP, Cohen J, Soper RJ, Roth LA. Laryngeal mask airway--a novel method of airway protection during ERCP: comparison with endotracheal intubation. Gastrointest Endosc 2002; 56:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/69\">",
"      Bower AL, Ripepi A, Dilger J, et al. Bispectral index monitoring of sedation during endoscopy. Gastrointest Endosc 2000; 52:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/70\">",
"      Wehrmann T, Grotkamp J, Stergiou N, et al. Electroencephalogram monitoring facilitates sedation with propofol for routine ERCP: a randomized, controlled trial. Gastrointest Endosc 2002; 56:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/71\">",
"      Balsells F, Wyllie R, Kay M, Steffen R. Use of conscious sedation for lower and upper gastrointestinal endoscopic examinations in children, adolescents, and young adults: a twelve-year review. Gastrointest Endosc 1997; 45:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/2/43049/abstract/72\">",
"      Etzkorn KP, Diab F, Brown RD, et al. Endoscopic retrograde cholangiopancreatography under general anesthesia: indications and results. Gastrointest Endosc 1998; 47:363.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2575 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-6F4C19BDB0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43049=[""].join("\n");
var outline_f42_2_43049=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28218957\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATIENTS WHO ARE LIKELY TO BE DIFFICULT TO SEDATE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H144782966\">",
"      ADJUNCTS TO MODERATE PROCEDURAL SEDATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H144783248\">",
"      Diphenhydramine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H144783255\">",
"      Droperidol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H144784449\">",
"      - Role for droperidol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H144784321\">",
"      - Administration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H144783277\">",
"      - Efficacy of droperidol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H144782877\">",
"      ALTERNATIVES TO MODERATE PROCEDURAL SEDATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Propofol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Efficacy of propofol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Balanced propofol sedation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Patient-controlled analgesia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28218864\">",
"      - Computer-assisted personalized sedation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H144784683\">",
"      - Administration by non-anesthesiologists",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Laryngeal mask airway",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H160962131\">",
"      - Bispectral (BIS) monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      General anesthesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H144784253\">",
"      Sedation-free endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28218957\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2575\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2575|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/43/12987\" title=\"table 1\">",
"      ASGE guideline anesthesiologist",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/25/17819\" title=\"table 2\">",
"      ASGE guideline droperidol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/60/13259\" title=\"table 3\">",
"      ASGE guideline personnel propaf",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/5/9307\" title=\"table 4\">",
"      ASA physical status scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/41/28310?source=related_link\">",
"      Complications of procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19817?source=related_link\">",
"      Overview of anesthesia and anesthetic choices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/22/24936?source=related_link\">",
"      Overview of procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34618?source=related_link\">",
"      Procedural sedation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/24/25993?source=related_link\">",
"      Screening for unhealthy use of alcohol and other drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/44/42694?source=related_link\">",
"      Sedation-free gastrointestinal endoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_2_43050="Disability letter";
var content_f42_2_43050=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F75264&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F75264&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    Sample clinician letter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 776px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: O'Connell, JJ, Zevin, BD, Quick, PD, et al. Documenting Disability: Simple Strategies for Medical Providers. The National Health Care for the Homeless Council's website, 2007. Available at: file://www.nhchc.org/DocumentingDisability.pdf. Copyright &copy; 2007 National Health Care for the Homeless Council.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43050=[""].join("\n");
var outline_f42_2_43050=null;
var title_f42_2_43051="Diagnosis of DiGeorge syndrome";
var content_f42_2_43051=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F55190&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F55190&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for DiGeorge syndrome",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Definitive diagnosis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Male or female patient with reduced numbers of CD3+ T cells (less than 500/mm",
"        <sup>",
"         3",
"        </sup>",
"        ) and two of the three following characteristics:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Conotruncal cardiac defect (truncus arteriosus, tetrology of Fallot, interrupted aortic arch, or aberrant right subclavian).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Hypocalcemia of greater than 3 weeks' duration that requires therapy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. Deletion of chromosome 22q11.2.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Probable diagnosis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Male or female patient with reduced numbers of CD3+ T cells (less than 1500/mm",
"        <sup>",
"         3",
"        </sup>",
"        ) and a deletion of chromosome 22q11.2.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Possible diagnosis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Male or female patient with reduced numbers of CD3+ T cells (less than 1500/mm",
"        <sup>",
"         3",
"        </sup>",
"        ) and at least one of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Cardiac defect.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Hypocalcemia of greater than 3 weeks' duration that requires therapy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3. Dysmorphic facies or palatal abnormalities.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Patients with a definitive or probable diagnosis are assumed to have a greater than 98 and 85 percent probability, respectively, that in 20 years they will still have the same diagnosis. Patients with a possible diagnosis are those that have some but not all of the characteristic clinical or laboratory findings of a particular disorder.",
"     <br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     From Conley, ME, Notarangelo, LD, Etzioni, A. Clin Immunol 1999; 93:190.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43051=[""].join("\n");
var outline_f42_2_43051=null;
var title_f42_2_43052="Ehrlichial infections";
var content_f42_2_43052=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F71243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F71243&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics of ehrlichial infections",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Species",
"       </td>",
"       <td class=\"subtitle1\">",
"        Natural host",
"       </td>",
"       <td class=\"subtitle1\">",
"        Disease(s)",
"       </td>",
"       <td class=\"subtitle1\">",
"        In vivo-infected cells",
"       </td>",
"       <td class=\"subtitle1\">",
"        Invertebrate vector",
"       </td>",
"       <td class=\"subtitle1\">",
"        Geographic distribution",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. chaffeensis",
"       </td>",
"       <td>",
"        Deer, human",
"       </td>",
"       <td>",
"        Human monocytic ehrlichiosis",
"       </td>",
"       <td>",
"        Monocytes macrophages",
"       </td>",
"       <td>",
"        Abylomma americanum",
"       </td>",
"       <td>",
"        United States, Europe, Africa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. sennetsu",
"       </td>",
"       <td>",
"        Human",
"       </td>",
"       <td>",
"        Sennetsu rickettsiosis",
"       </td>",
"       <td>",
"        Monocytes macrophages",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Japan, Malaysia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Human granulocytic ehrlichia",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"       <td>",
"        Human granulocytic ehrlichiosis",
"       </td>",
"       <td>",
"        Granulocytes",
"       </td>",
"       <td>",
"        Ioxodes scapularis (suspected)",
"       </td>",
"       <td>",
"        Midwestern United States",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. canis",
"       </td>",
"       <td>",
"        Dogs",
"       </td>",
"       <td>",
"        Canine ehrlichiosis, tropical canine pancytopenia",
"       </td>",
"       <td>",
"        Monocytes macrophages",
"       </td>",
"       <td>",
"        R. sanguineus",
"       </td>",
"       <td>",
"        Worldwide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. risticii",
"       </td>",
"       <td>",
"        Horse",
"       </td>",
"       <td>",
"        Equine monocytic ehrlichiosis (Potomac horse fever)",
"       </td>",
"       <td>",
"        Monocytes macrophages, interstitial epithelial cells, mast cells",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        North America, Europe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. equi",
"       </td>",
"       <td>",
"        Horse",
"       </td>",
"       <td>",
"        Equine ehrlichiosis",
"       </td>",
"       <td>",
"        Granulocytes",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        United States, Europe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. phagocytophilia",
"       </td>",
"       <td>",
"        Sheep, cattle, bison",
"       </td>",
"       <td>",
"        Tick-borne fever",
"       </td>",
"       <td>",
"        Granulocytes",
"       </td>",
"       <td>",
"        I. ricinus",
"       </td>",
"       <td>",
"        Great Britain, Europe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. bovis and E. ovina",
"       </td>",
"       <td>",
"        Cattle, sheep",
"       </td>",
"       <td>",
"        Bovine and ovine ehrlichioses",
"       </td>",
"       <td>",
"        Monocytes macrophages",
"       </td>",
"       <td>",
"        Hyalomma rhipicep halus, H. bursa",
"       </td>",
"       <td>",
"        Middle East, Africa, Sri Lanka",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. ondiri",
"       </td>",
"       <td>",
"        Cattle, sheep",
"       </td>",
"       <td>",
"        Bovine petechial fever (Ondiri disease)",
"       </td>",
"       <td>",
"        Granulocytes",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Kenya",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E. platys",
"       </td>",
"       <td>",
"        Dogs",
"       </td>",
"       <td>",
"        Canine cyclic thrombocytopenia",
"       </td>",
"       <td>",
"        Platelets",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        United States",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43052=[""].join("\n");
var outline_f42_2_43052=null;
var title_f42_2_43053="Rx serious MRSA child";
var content_f42_2_43053=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Parenteral antimicrobial regimens for definitive treatment of bacteremia and other serious methicillin-resistant* Staphylococcus aureus infection in children older than 30 days when antimicrobial susceptibilities are known",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Antimicrobial regimen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Doses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Life-threatening infection (eg, endocarditis, central nervous system infection, septic shock)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Regimen of choice",
"       </td>",
"       <td>",
"        <p>",
"         Vancomycin &plusmn;",
"        </p>",
"        <p>",
"         Rifampin",
"         <sup>",
"          &bull;",
"         </sup>",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Vancomycin: 60 mg/kg per day in 4 doses; maximum daily dose 4 g",
"        </p>",
"        <p>",
"         Rifampin: 20 mg/kg per day in 2 doses; maximum daily dose 600 mg",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alternative regimen, excluding CNS infections and pneumonia (also may be used for patients with persistent bacteremia despite adequate therapy)",
"       </td>",
"       <td>",
"        Daptomycin",
"        <sup>",
"         &Delta;&loz;",
"        </sup>",
"       </td>",
"       <td>",
"        9 mg/kg",
"        <sup>",
"         &sect;",
"        </sup>",
"        per day in 1 dose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Nonlife-threatening, nonendovascular infection (eg, pneumonia, septic arthritis, osteomyelitis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Regimens of choice",
"       </td>",
"       <td>",
"        <p>",
"         Clindamycin",
"         <sup>",
"          &yen;",
"         </sup>",
"         (if strain susceptible and D-test negative),",
"         <strong>",
"          or",
"         </strong>",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         40 mg/kg per day in 3 to 4 doses; maximum daily dose 1.2 to 2.7 g",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vancomycin",
"       </td>",
"       <td>",
"        60 mg/kg per day in 4 doses; maximum daily dose 4 g",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alternative regimen for pneumonia",
"       </td>",
"       <td>",
"        Linezolid",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        <p>",
"         &lt;12 years: 30 mg/kg per day in 3 doses",
"        </p>",
"        <p>",
"         &ge;12 years: 600 mg twice per day",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Alternative regimens for septic arthritis, osteomyelitis",
"       </td>",
"       <td>",
"        Daptomycin",
"        <sup>",
"         &Delta;&loz;",
"        </sup>",
"       </td>",
"       <td>",
"        9 mg/kg&sect; per day in 1 dose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Linezolid",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        <p>",
"         &lt;12 years: 30 mg/kg per day in 3 doses",
"        </p>",
"        <p>",
"         &ge;12 years: 600 mg twice per day",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Complicated skin and soft-tissue infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Regimens of choice",
"       </td>",
"       <td>",
"        Clindamycin (if strain susceptible and D-test negative)",
"        <sup>",
"         &yen;",
"        </sup>",
"        ,",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"       <td>",
"        30 to 40 mg/kg per day in 3 to 4 doses; maximum daily dose 1.2 to 2.7 g",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trimethoprim-sulfamethoxazole",
"       </td>",
"       <td>",
"        8 to 12 mg/kg trimethoprim/40 to 60 mg/kg sulfamethoxazole per day in 4 doses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Alternative regimens",
"       </td>",
"       <td>",
"        Vancomycin",
"       </td>",
"       <td>",
"        40 to 60 mg/kg per day in 4 doses; maximum daily dose 4 g",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Linezolid",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        <p>",
"         &lt;12 years: 30 mg/kg per day in 3 doses",
"        </p>",
"        <p>",
"         &ge;12 years: 600 mg twice per day",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CNS: central nervous system.",
"     <br>",
"      * Oxacillin minimum inhibitory concentration (MIC) &ge;4 mcg/mL.",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       Rifampin may be added for life-threatening infections such as endocarditis or central nervous system infection, although there are no data from controlled trials to indicate that combination therapy is beneficial. Rifampin may be added for any methicillin-resistant",
"       <em>",
"        Staphylococcus aureus",
"       </em>",
"       (MRSA) infection of prosthetic material. Gentamicin (3 mg/kg per day for&nbsp;two weeks) is added to vancomycin and rifampin as recommended treatment of MRSA prosthetic valve endocarditis. Consultation with an expert in infectious diseases may be warranted to determine which agent to use and duration of use.",
"       <br>",
"        &Delta; Consultation with an expert in infectious diseases is suggested before use.",
"        <br>",
"         <font class=\"lozenge\">",
"          &loz;",
"         </font>",
"         Daptomycin is active in vitro against multidrug-resistant gram-positive organisms, including",
"         <em>",
"          S. aureus",
"         </em>",
"         , but is not well studied in children. It is approved by the United States Food and Drug Administration only for the treatment of complicated skin and skin-structure infections in patients &ge;18 years of age. Daptomycin should not be used alone if pulmonary infection is present. There is no experience with daptomycin in the treatment of central nervous system infections.",
"         <br>",
"          &sect; May need to increase dose to 10 to 12 mg/kg per day to reach concentrations efficacious in adults.",
"          <br>",
"           &yen; Once bacteremia is cleared.",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Staphylococcal infections. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29",
"        <sup>",
"         th",
"        </sup>",
"        ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.653.",
"       </li>",
"       <li>",
"        American Academy of Pediatrics. Tables of antibacterial drug dosages. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29",
"        <sup>",
"         th",
"        </sup>",
"        ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.807.",
"       </li>",
"       <li>",
"        Liu C, Bayer A, Cosgrove SE, et, al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.",
"       </li>",
"       <li>",
"        Safety and Efficacy Study of Daptomycin in Pediatric Subjects (2-17 Years)With Skin and Skin Structure Infections. Available at:",
"        <a href=\"file://clinicaltrials.gov/ct2/show/NCT00711802\">",
"         clinicaltrials.gov/ct2/show/NCT00711802",
"        </a>",
"        . Accessed on August 2, 2012.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43053=[""].join("\n");
var outline_f42_2_43053=null;
var title_f42_2_43054="Circadian silent ischemia";
var content_f42_2_43054=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66796&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66796&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 579px\">",
"   <div class=\"ttl\">",
"    Circadian pattern of silent ischemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 559px; height: 407px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The 24-hour distribution of silent ischemic events during continuous electrocardiographic monitoring parallels the circadian pattern of heart rate (HR) and systolic blood pressure (SBP). Note the simultaneous and significant increases in both the double product and silent ischemic events between 6:00 and 7:00 AM.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Deedwania PC, Nelson J. Circulation 1990; 82:1296.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43054=[""].join("\n");
var outline_f42_2_43054=null;
var title_f42_2_43055="Foraminal encroachment xray";
var content_f42_2_43055=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F78738&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F78738&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 475px\">",
"   <div class=\"ttl\">",
"    Oblique neck film for foraminal encroachment",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 455px; height: 433px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Oblique views are primarily used to determine the role of foraminal encroachment. This 54-year-old patient presented with a gradual onset of numbness and tingling of the middle fingers of the right hand. Symptoms waxed and waned over a period of several months. The triceps reflex and muscle strength were normal. The oblique film demonstrates C6-7 foraminal encroachment.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_2_43055=[""].join("\n");
var outline_f42_2_43055=null;
